US20080243140A1 - Spacing devices for releasing active substances in the paranasal sinus - Google Patents

Spacing devices for releasing active substances in the paranasal sinus Download PDF

Info

Publication number
US20080243140A1
US20080243140A1 US12/138,364 US13836408A US2008243140A1 US 20080243140 A1 US20080243140 A1 US 20080243140A1 US 13836408 A US13836408 A US 13836408A US 2008243140 A1 US2008243140 A1 US 2008243140A1
Authority
US
United States
Prior art keywords
spacing device
paranasal sinus
sinus
stent
active substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/138,364
Inventor
Achim Gopferich
Werner Hosemann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Acclarent Inc
Original Assignee
Acclarent Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acclarent Inc filed Critical Acclarent Inc
Priority to US12/138,364 priority Critical patent/US20080243140A1/en
Publication of US20080243140A1 publication Critical patent/US20080243140A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08Materials for coatings
    • A61L31/10Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/18Internal ear or nose parts, e.g. ear-drums
    • A61F2/186Nose parts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/22Lipids, fatty acids, e.g. prostaglandins, oils, fats, waxes
    • A61L2300/222Steroids, e.g. corticosteroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/258Genetic materials, DNA, RNA, genes, vectors, e.g. plasmids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412Tissue-regenerating or healing or proliferative agents
    • A61L2300/414Growth factors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/43Hormones, e.g. dexamethasone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/432Inhibitors, antagonists
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/432Inhibitors, antagonists
    • A61L2300/434Inhibitors, antagonists of enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602Type of release, e.g. controlled, sustained, slow

Definitions

  • the present invention relates to a spacing device (stent) for use in fenestrations of the paranasal sinus.
  • the paranasal sinus system consists of a series of cavities lined with mucous membrane and filled with air.
  • the interruption of the natural secretion drainage from the remote paranasal sinus portions and the removal of natural ventilation are important in the occurrence of chronic sinusitis.
  • the remote, diseased paranasal sinus portions are accordingly reventilated during cleaning-up interventions through newly created or extended accesses (“windows”). After healing, the natural secretion drainage of these reventilated compartments reappears.
  • frontal sinus mucous membrane is involved in the inflammatory modification of the sinus a surgical fenestration takes place towards the nose. This is carried out with special instruments (bent sharp spoons, special stamps, drills). Accesses of about 5 to a maximum of 10 mm in diameter are produced by routine “fenestration” of the frontal sinus. During healing of the wound these accesses narrow by about 1.5 mm.
  • the neo-ostium to the front sinus narrows to a greater or lesser extent, according to experience.
  • a spacing device usually had the form of a small tube and were made of various materials: at the beginning rolled metal or metal braided in wires was used (Fletscher Ingals E: New operation and instruments for draining the frontal sinus.
  • Good R H An intranasal method for opening the frontal sinus establishing the largest possible drainage.
  • the presently described problems show the need for systems which can in a controlled manner dispense the active substances such as, for example, corticosteroids over a longer period directly to the operation site.
  • the polymers used for such applications include, apart from biodegradable materials, non-biodegradable materials, i.e. those which do not decompose on contact with body fluids.
  • examples of such polymers are silicone, polyacrylate and ethylene vinyl acetate copolymer (U.S. Pat. No. 4,069,307).
  • the last polymer group, in particular, was used for a series of systems for controlled release of active substances.
  • U.S. Pat. No. 3,393,073 thus describes a so-called reservoir system consisting of a medicinal substance reservoir which is surrounded by a polymer sheath regulating the release rate of the medicinal substance.
  • Such systems were successfully used for the development of “intra-uterine devices” which release the active substance in the uterus (U.S. Pat. No. 3,967,618 and U.S. Pat. No. 4,016,251) and for producing therapeutic systems which release medicinal substances to the eye (U.S. Pat. No. 4,052,505).
  • Such systems were also described, as carrier systems with a microporous membrane controlling the discharge of the active substance, for introduction into various body cavities, such as for example, the ear, nose or the rectum (U.S. Pat. No. 3,948,254).
  • stents for the treatment of paranasal sinuses, such as, for example in U.S. Pat. No. 5,693,065 or U.S. Pat. No. 5,336,163.
  • U.S. Pat. No. 5,693,065 describes a stent for the nose area made of silicone rubber having a cylindrical shaft of which the leading end to be inserted into the nose is designed in the shape of the point of a spear, the base of the point connected to the shaft having a wider diameter than the shaft. The point is closed at the front and laterally has ribs with slits therebetween, the ribs expanding in the inserted state and thus ensuring the hold of the stent in the nose area.
  • U.S. Pat. No. 5,336,163 relates to a stent for the nose area formed from a porous material and having a non-adhering, but slightly porous outer surface.
  • the stent is formed from a material here which expands on contact with liquid.
  • U.S. Pat. No. 5,601,594 describes a stent for insertion into a nose aperture, the stent having a bent shape and being formed from a compressible material.
  • U.S. Pat. No. 5,980,551 describes a stent for blood vessels, the stent having an inner support structure which may be formed from a wire and the support structure is surrounded by a biodegradable resorbable substrate. Biologically active microparticles which release active substances in a controlled manner can be embedded into this substrate.
  • Stents for suppressing the restenosis of coronary arteries have design features which clearly differ from the subject of the invention and therefore also make them unsuitable for application in the frontal sinus.
  • Coronary stents generally consist of a stent body such as, for example, a wire braiding covered with medicinal substance-carrying polymers or sheathed in thin polymer films (U.S. Pat. No. 5,824,048, U.S. Pat. No. 5,700,286, U.S. Pat. No. 5,837,313, U.S. Pat. No. 5,679,400).
  • the mechanical stability of these stents is geared to the needs of arteries and makes them unsuitable for application in the nasal sinus, as they are not mechanically stable enough.
  • Coronary stents are rotationally symmetrical hollow bodies and preferably have the geometry of a hollow cylinder. They can therefore not be fixed via thickenings at the cylinder end in a fenestration of the paranasal sinus. Moreover, a fenestration of the paranasal sinus is generally not uniformly round, but more or less irregular which creates additional problems with respect to anchoring. In general, coronary stents cannot have large wall thicknesses so as not to impede the blood flow.
  • coronary stents differ from spacing devices for paranasal sinuses due to their function.
  • the coronary stent is intended to expand the vessel in many cases.
  • the front sinus spacing device on the other hand, is inserted in a surgically applied passage which has bony (stable) walls. This passage was surgically newly formed; the coronary artery, on the other hand is left as a tube, but expanded.
  • a coronary stent is a permanent implant, it is completely absorbed by the body.
  • the frontal sinus spacing device is removed after a period of about 8 weeks.
  • the coronary stent is completely absorbed by the body. Blood flows in the interior of the coronary stent; the wall is completely colonised in the most favourable case by the body's own cells (endothelial cells). With the frontal sinus spacing device, complete absorption into the body is not desirable. Secretion from the mucous membrane surface should drain in the interior of the frontal sinus spacing device and ventilation should simultaneously be ensured. Colonisation of the interior of the spacing device with the body's own cells is neither anticipated nor desired.
  • the mucous membrane should widen at the outside of the frontal sinus spacing device. In this manner, once the spacing device has been removed, a passage lined with intact mucous membrane should remain.
  • a problem in the coronary stent is the formation of a clot with the risk of an occlusion which has to be suppressed by the administration of special medication.
  • the frontal sinus spacing device does not require the administration of special medication.
  • WO 96/29071 describes medical devices such as catheters or stents, on the surface of which antibacterial means are applied, the antibacterial means adhering to the surface owing to adhesive forces, without further aids being required.
  • the spacing device according to the invention allows an adequately large quantity of active substance to be received and stored, without impairment of the controlled release owing to interactions of the active substance contents.
  • the ratio q of the external diameter r a to the internal diameter r i of the stent body is a value of 1.2 and more.
  • the ratio q is selected in a range of 1.2 ⁇ q ⁇ 3.0, in particular of 1.2 ⁇ q ⁇ 2.8, preferably of 1.5 ⁇ q ⁇ 2.5 and particularly preferably 1.8 ⁇ q ⁇ 2.2.
  • the value q is typically in a range of less than 1.2.
  • the quotient q can thus serve as the calculation basis here.
  • the volume V can be calculated from the height h, the internal diameter r i and q:
  • the diffusion section in a hollow cylinder can be estimated as half the difference between external diameter r a and external diameter r i .
  • the release duration is reduced to 4% when q is reduced from 2 to 1.2.
  • the value q is preferably above 1.2 and in particular in a range 1.2 ⁇ q ⁇ 2.8, particularly preferably 1.5 ⁇ q ⁇ 2.5 and particularly preferably the range is 1.8 ⁇ q ⁇ 2.2.
  • the invention relates to a spacing device for the paranasal sinus in which the layer or layers loaded with active substance are separated towards the inner cavity by a layer consisting of a material which is impermeable or at least virtually impermeable for the active substance. Active substance losses are thus avoided and the duration over which the active substance is released is simultaneously increased.
  • Coronary stents which are introduced via a catheter into the blood vessels have to be plastically, i.e. irreversibly deformable. Owing to an irreversible widening of the stent, they have to be fixed to the vessel wall.
  • the spacing device developed in the course of this invention for use in the paranasal sinus, in contrast thereto, is distinguished by elastic properties and therefore reversible deformability; the paranasal sinus spacing device can be fixed simply in the apertures to the paranasal sinus, inter alia owing to this elasticity.
  • spacing device (stent) loaded with active substance according to the invention to keep the frontal sinus accesses open not only by a physical/mechanical mechanism, but also by a pharmacological mechanism.
  • These spacing devices are adapted to the surgically created accesses to the paranasal sinus and fulfil two functions:
  • the developed spacing devices may release active substances such as medicinal substances such as, for example corticosteroids which suppress tissue formation or overshooting wound healing and therefore keep open the surgically newly created fenestration.
  • active substances such as medicinal substances such as, for example corticosteroids which suppress tissue formation or overshooting wound healing and therefore keep open the surgically newly created fenestration.
  • the “stent” has some design features which will be described in more detail hereinafter with the aid of the figures.
  • the spacing device according to the invention is a hollow body which is composed of a sheath surrounding an inner cavity and having a respective aperture at two opposing ends.
  • the hollow body is preferably based on a cylindrical shape wherein it can deviate from the ideal cylindrical form with an in particular uniform diameter along the shaft.
  • the external diameter along the cylinder shaft may thus vary, for example the external diameter in the end regions close to the apertures may be selected to be larger than in the central shaft region.
  • the external diameter may continuously reduce in the direction of the central shaft region, may be reduced in the manner of an hourglass in the central region, wherein the specific shape of the cylindrical basic body can be adapted in any way as necessary.
  • the wall thickness of the cylinder may also be selected to be variable.
  • FIG. 1 shows a preferred configuration according to the invention of the spacing device in cylindrical form
  • FIG. 2 shows the top view of a cross-section through a spacing device loaded with active substance according to the invention
  • FIG. 3 shows the top view of a cross-section of another preferred configuration of the spacing device according to the invention as a reservoir system with a plurality of layers
  • FIG. 4 shows a further configuration of the spacing device according to the invention with perforations in the sheath
  • FIG. 5 shows a configuration of the spacing device according to the invention, wherein the external diameter of the cylindrical shaft in the end regions is greater than towards the centre and furthermore the wall thickness increases towards the centre of the cylinder shaft,
  • FIG. 6 shows a further configuration of the spacing device according to the invention as a matrix system with a plurality of layers
  • FIG. 7 is a graph with the release curve of an active substance from a preferred layer material according to the invention.
  • the geometry of the spacing device is preferably that of a hollow cylinder as can be seen in FIG. 1 , wherein a sheath 1 surrounds an inner cavity having apertures 2 at the two opposing ends of the cylinder shaft.
  • This cylinder form encourages the secretion drainage from the sinuses owing to its tubular design.
  • the length of the cylinder is preferably selected here in a range of 5 to 30 mm and its external diameter in a range of 1 to 30 mm.
  • the wall thickness is to be selected according to need as a function of the physical properties of the polymer materials used and the active substances used and the desired release profile within the above-mentioned ranges for the ratio q of external diameter to internal diameter.
  • the at least two inner apertures 2 typically have a diameter in a range of 0.5 to 25 mm.
  • FIG. 2 shows an example of a spacing device with a monolithic construction, wherein the sheath 1 is composed of a single layer and the layer material forms the matrix for the active substance.
  • FIG. 3 shows an example of a configuration of the spacing device according to the invention as a reservoir system, wherein the active substance is contained in a reservoir 4 .
  • the active substance is not contained in a matrix material, unlike in the matrix system.
  • the active substance may here directly form the layer forming the reservoir or the active substance may be provided in a corresponding cavity.
  • the latter case is suitable in particular for liquid or semi-solid active substances or for liquid or semi-solid carriers containing the active substance.
  • the active substance to be released may also be dissolved or suspended in the reservoir system.
  • the release-controlling material forming the cavity for example a reservoir 4 is surrounded by an outer membrane 3 which preferably consists of a polymer material through which the active substance can diffuse.
  • the cavity forming the reservoir 4 is preferably separated on the inside to the inner cavity 3 by an inner wall 4 preferably consisting of a material which is impermeable or virtually impermeable to the active substance.
  • An inner layer (inner wall 4 ) which is as impermeable as possible to the active substance is suitable in principle for any active substance-carrying systems for avoiding active substance losses in the direction of the inner cavity 3 .
  • the inner wall 4 may consist here of a corresponding polymer material but also of an inorganic material such as a metal etc.
  • the sheath 1 may have perforations 7 , as shown in FIG. 4 , which connect the inner cavity 3 to the outer surface of the stent.
  • the secretion drainage can also be assisted by this measure.
  • perforations 7 can be freely selected here as required.
  • FIG. 5 A configuration according to the invention with a varying external diameter is shown in FIG. 5 .
  • the external diameter of the stent is selected to be greater at the end regions with the apertures 2 than in the central region and decreases continuously towards the centre.
  • the wall thickness may also vary, wherein it decreases in this case towards the end regions.
  • the wall thickness in other words the ratio q of external diameter to internal diameter may, as required, in particular in the end regions or else in short central sections be outside the value to be adjusted according to the invention for q, if the usability of the stent is not impaired.
  • at least in the wound regions q should be within the above-mentioned value range according to the invention of 1.2 ⁇ q ⁇ 3.0.
  • these regions or this range should not be more than 30% of the hollow body.
  • the stent according to the invention may be formed from one or more layers, wherein the layers may consist of the identical and/or different polymers. Individual regions of a layer, for example the end regions close to the apertures 2 may be manufactured from a material which is different from the material for the remaining layer regions. In other words one layer may contain at least one region which is formed from a different material than the remaining layer.
  • the stent according to the invention may have layers which are free of active substance in addition to layers which are loaded with active substance.
  • the stent according to the invention may be surrounded by a suitable outer coating.
  • the spacing device according to the invention does not necessarily lie homogenously and in a planar manner on the tissue. This circumstance requires a particular construction so that, for example, secretion cannot build up in the long term between the spacing device and the sinus wall. Secretion drainage can be facilitated by perforations 7 in the wall of the spacing device (see cross-section shown in FIG. 4 ). With respect to its form the spacing device may show an “hourglass-shaped”transition zone from the front sinus to the nasal interior ( FIG. 5 ) and permits endoscopy of the sinus through a central aperture.
  • the space holder may have irregularities such as humps etc. on its outer surface.
  • irregularities such as humps etc.
  • contact with the nasal wall is via these irregularities, wherein, on the one hand, the contact face can be reduced and an adequately firm hold is nevertheless ensured.
  • the developing cavities between the outer surface of the stent and nasal wall simultaneously encourage secretion drainage.
  • the spacing device is moreover advantageously provided such that suction of the paranasal sinus remains possible owing to the spacing device. This is made possible owing to a relatively small length.
  • the spacing device is therefore preferably constructed such that it can be cut to the desired length directly prior to application.
  • the spacing device must be “anchored” counter to gravity in the frontal sinus entry. This anchoring can be achieved by a “ballooning” of the implant, i.e. a widening of the spacing device end in the frontal sinus or fixing by means of a seam on the nasal septum.
  • the stent may consist of materials which favour anchoring and shape adaptation.
  • shape memory polymers for example U.S. Pat. No. 5,139,832, U.S. Pat. No. 5,189,110
  • swelling polymers for example DE 4 032 096
  • FIG. 6 An example of this is shown in FIG. 6 , wherein the outer layer 9 consists of a deformable polymer and surrounds a polymer layer 8 loaded with active substance.
  • the spacing device in the nose in contrast to spacing devices in vessels, is exposed to a bacteria-loaded environment (mucous membrane wounds with free contact to the outside air). Owing to corresponding shaping, scab formation and bacterial contamination is delayed. This may, for example, be achieved by an adequately large internal diameter of the spacing device encouraging secretion drainage.
  • the materials used may moreover be modified at the surface in such a way that secretion drainage is encouraged and bacterial contamination is avoided.
  • An example is the hydrophilising of the surface.
  • the interior of the hollow body can be lined with a polymer layer which is highly wettable and preferably has water contact angles ⁇ 45°.
  • polymers can be used, the surface of which has been chemically modified, such as, for example, by the chemical bonding of hydrophilic substances or by treatment with gas plasma.
  • the spacing device may also be loaded with bactericidally or bacteriostatically active substances.
  • the design of the matrix system may above all consist of a plurality of polymer layers as the cross-section in FIG. 6 shows by way of example.
  • the number of layers is not limited to 2 as shown in the figure.
  • a plurality of layers which fulfil different functions can be combined with one another.
  • Individual layers may be free of medicinal substance or be loaded with one or more medicinal substances. In loading different layers with various medicinal substances, the latter may be released from the spacing device with different kinetics.
  • the thickness of individual polymer layers may be thin, as desired, for example in the range of a few micrometres.
  • the spacing device may also be already preformed prior to application or else be shaped to its final geometry by processing a precursor.
  • Methods, such as, for example, extrusion or injection moulding are excellently suited to producing preformed spacing devices.
  • polymer films may for example be rolled to form hollow bodies and fixed by a seam.
  • the materials from which the spacing device can be produced may be biodegradable or else non-biodegradable materials or a combination thereof.
  • biodegradable materials are polymers of lactic acid or glycolic acid and their copolymers. Further suitable examples are to be found in the literature (K. Park, W. S. W. Shalaby, H. Park, Biodegradable Hydrogels for Medicinal substance Delivery, Technomic Publishing Inc. Lancaster 1993; A. Domb, J. Kost, D. M. Wiseman, Handbook of Biodegradable Polymers, Harwood Academic Publishers, 1997).
  • biodegradable materials have the advantage of not having to be removed after application, non-biodegradable materials can be better fixed in the region of use of the spacing device.
  • examples of such materials are silicones, polyacrylates and polymethacrylates and the copolymers thereof (Eudragit®)), poly(ethylene vinyl acetate) copolymer and other compositions as described in the polymer literature and known for medical applications.
  • the polymers should preferably be flexible so that they adapt to the wound area. Moreover, they should be elastic enough to remain in the fenestration and should be biocompatible, in other words have good tolerability with respect to cells and tissues.
  • the polymers mentioned can be combined with other materials, such as for example metals to ensure a reliable seat of the “stent” with smaller wall thicknesses. These metals can be incorporated into the wall of the cylinder.
  • the polymers can be processed by various industrial methods to form the spacing devices shown in FIGS. 1 and 2 , thus, for example by extrusion or injection moulding or by polymerisation in suitable moulds.
  • the casting of polymer solutions is a simple production method (solvent casting).
  • solvent casting For this purpose the polymers are dissolved in organic solvents and the solution is poured or sprayed onto an inert surface. After evaporation of the solvent dry polymer films loaded with active substance are obtained which can be cut into any, for example rectangular forms.
  • tubes are directly obtained by extrusion or injection moulding
  • small individually adapted tubes can be formed from rectangular polymer films directly before insertion into the patient. This may take place by repeated rolling of the polymer film or by mechanical adhesion or sticking of opposing film edges.
  • the polymer properties can be controlled such that either smooth or porous surfaces are produced. This influences the rate of active substance administration and optionally the interaction between the spacing device and wound edges.
  • the surfaces of the spacing device towards the tissue and the secretion side may also be changed such that they optimally do justice to the requirements of their functions.
  • the inside of the cylinder to the cavity of the spacing device may, for example be physico-chemically changed on its surface such that there can be improved wetting with secretion and therefore improved secretion drainage. Examples are the above-mentioned hydrophilising of surfaces or the covalent bonding of hydrophilic substances to the polymer surfaces.
  • the surface to the tissue side may be chemically changed such that the tissue compatibility is improved. This can be achieved by a coating with materials in the form of thin films or connection or application of functional groups or whole molecules which interact with the biological system.
  • the anchoring of polyethylene glycol chains to the surface leads to a reduced cell attachment and this facilitates the removal of the spacing device and increases it compatibility with the wound tissue.
  • the active substances can be selected according to need, application, desired property etc. They can also be used in combination.
  • the stents according to the invention are loaded with medicinal substances.
  • Substances are generally used as medicinal substances which may influence the behaviour of cells and tissues, in particular they should prevent uncontrolled tissue growth.
  • representatives of the group of glycocorticosteroids are suitable, such as for example cortisol, corisone, prednisone, prednisolone, 6-methylprednisolone, dexamethasone, fludrocortisone, desoxycorticoacetate.
  • proteins from the area of cytokines and growth factors which are also said to have some cell growth-inhibiting properties.
  • tyrosine kinase inhibitors, antisense-oligonucleotides and mitosis inhibitors such as mitomycin are suitable for eliminating the proliferative influence of growth factors during wound healing.
  • the active substances can be released from the spacing device over a long time period. Depending on the design and the material used, releases can be carried out for up to several years. Release preferably extends over a time period of 2 to 12 weeks. Principles controlling the release include, apart from the wall thickness expressed as the ratio q, primarily diffusion and polymer swelling for non-biodegradable polymers. When using biodegradable materials, i.e. those which dissolve during use, polymer erosion also plays an important part (Gopferich, Polymer Degradation and Erosion: Mechanismus and Applications, Eur. J. Pharm. Biopharm., 42 (1996) 1-11).
  • the active substance is preferably released from the reservoir or a matrix system. In both cases, the active substance is released in the process by diffusion.
  • the release of active substance can be influence by a plurality of factors. By changing the geometry the active substance can be released over different lengths of time. Furthermore, it is possible to control the kinetics of the active substance release by the degree of loading.
  • the loading in particular in the embodiment as a matrix system, is preferably in a range up to 30% by weight based on the total system.
  • the minimum loading depends inter alia on the potency of the active substance and on the desired duration of release.
  • diffusion additives can be added to the polymer matrix or the polymers.
  • Inert inorganic materials such as, for example silicone dioxide thus lead to a reduction in the rate of release.
  • the rate of release can be increased by plasticiser additives.
  • swelling can be increased by osmotic additives into the polymer and the rate of release can therefore be increased depending on the active substance properties.
  • the type of biodegradable polymer can be geared to the application.
  • poly(D,L-lactide-co-glycolide) that the rate of release and the rate of erosion can be controlled by the increase in the glycolide content.
  • the subject of the invention is a spacing device (stent) which after surgical opening of the paranasal sinus (mainly the frontal sinus) is inserted into the created fenestration to the nose.
  • the newly developed spacing device prevents a post-operative scarred narrowing in that it combines two conventional treatment attempts for the surgically newly created frontal sinus access:
  • the spacing device acts as a physical barrier which mechanically keeps the access to the frontal sinus open.
  • the spacing device releases medicinal substances which control the growth of the tissue around the newly created access to the front sinus.
  • the material of the spacing device preferably has the mechanical properties of an elastomer such as, for example silicone, a proven material in ENT surgery for spacing devices. Owing to the preferred geometry which corresponds substantially to that of a hollow cylinder, secretion can drain from the sinuses. Moreover, the material acts as a local release system for medicinal substances such as for example corticosteroids. Owing to the shape and function the stent ensures a firm seat and simultaneously allows optimum secretion drainage. The continuous release of a defined quantity of medicinal substance is preferably ensured over a period of 8 weeks. The anticipated duration in position of the implant is preferably also 8 weeks. For production, films loaded with medicinal material, for example, can be rolled to form a cylinder and stabilised with a surgical seam.
  • an elastomer such as, for example silicone
  • the spacing device is inserted intra operationem into the newly created frontal sinus access. If necessary, it is fixed in the operation area by its particular form, the materials used, its construction and/or by a surgical seam to prevent displacement. Apart from the use in fenestrations to the paranasal sinus, use is possible in the middle ear and the trachea.
  • the film has the following composition:
  • the polymer used a poly(ethylene-vinyl acetate) copolymer is initially freed of additives which were added during the production of Evatane 40-55.
  • 50 g of Evatane 40-55 are also weighed out into a 500 ml iodine measuring cylinder with a magnetic stirring rod.
  • 250 ml acetone p.a. are measured with a measuring cylinder and added to the polymer.
  • the batch is stirred on the magnetic stirrer for about a week and the acetone is then decanted.
  • the polymer is washed 3 times with 80 ml acetone p.a. and the washing liquid discarded.
  • the extraction and washing procedure is repeated once with acetone and twice with ethanol using the same volumes.
  • the polymer is then dried in a crystallising dish in a laminar airflow box for 48 h and then in a desiccator under vacuum.
  • Evatane 40-55 are then weighed out into a 250 ml iodine value vessel.
  • the dichloromethane is added thereto and stirred on the magnetic stirrer over 12 h.
  • the dexamethasone is dissolved in acetone and added to the polymer solution.
  • the batch is then left to stand for 10 min without stirring to remove air bubbles.
  • the solution is poured into a planar Teflon mould with an area of 15 cm 2 and dried in a laminar airflow box over 4 days.
  • the dried film is drawn from the Teflon mould and cut into pieces of any size.
  • the film thickness is about 0.8 to 1 mm.
  • the polymer films are rolled to form a hollow cylinder and preferably fixed by a seam with a biocompatible seam material at the contact points in such a way that the cylinder does not unwind owing to the elasticity of the material.
  • the small tube formed in this way is then inserted into the fenestration to the paranasal sinus.
  • FIG. 7 shows the release of dexamethasone over the time.

Abstract

The invention relates to a spacing device (stent) for use in fenestrations of the paranasal sinus. Said device consists of a sheath which forms a hollow body, surrounding an internal cavity. An active substance, which is released in a controlled manner by the spacing device, is contained in the sheath or in at least one layer of the sheath. The relationship q of the external diameter of the hollow body to the internal diameter of the hollow body is expressed by 1.2≦q≦3.0.

Description

    RELATED APPLICATIONS
  • This patent application is a division of copending U.S. patent application Ser. No. 10/470,881 filed Feb. 4, 2004 which is a national stage filing under 35 U.S.C. § 371 of PCT/EP02/01228 filed Feb. 6, 2004, which claims priority to German Patent Application No. DE10105592.7 filed Feb. 6, 2001, the entire disclosure of each such application being expressly incorporated herein by reference.
  • FIELD OF INVENTION
  • The present invention relates to a spacing device (stent) for use in fenestrations of the paranasal sinus.
  • BACKGROUND OF INVENTION
  • About 5% of our population suffer from a chronic mucous membrane inflammation of the paranasal sinuses. In the course of an inflammation of this type, nasal polyps occur in every fifth patient. If corresponding symptoms occur and an attempt at medicinal treatment remains unsuccessful, the chronic sinusitis is approached surgically.
  • The paranasal sinus system consists of a series of cavities lined with mucous membrane and filled with air. The interruption of the natural secretion drainage from the remote paranasal sinus portions and the removal of natural ventilation are important in the occurrence of chronic sinusitis. The remote, diseased paranasal sinus portions are accordingly reventilated during cleaning-up interventions through newly created or extended accesses (“windows”). After healing, the natural secretion drainage of these reventilated compartments reappears.
  • Surgical treatment of chronic sinusitis has been transformed after the introduction of modern optical aids (rigid endoscopes, microscope). Nowadays, the “minimally invasive” clearing exclusively of those mucous membrane parts which have undergone an obviously irreversible change owing to the inflammation process predominates. Other reversibly changed or unaffected mucous membrane areas are spared as far as possible (Hosemann W G, Weber R K, Keerl R E, Lund V J: Minimally invasive endonasal sinus surgery. Thieme, Stuttgart, New York 2000).
  • If the frontal sinus mucous membrane is involved in the inflammatory modification of the sinus a surgical fenestration takes place towards the nose. This is carried out with special instruments (bent sharp spoons, special stamps, drills). Accesses of about 5 to a maximum of 10 mm in diameter are produced by routine “fenestration” of the frontal sinus. During healing of the wound these accesses narrow by about 1.5 mm.
  • If certain health factors are present, such as, for example intolerance of analgesics, a disproportionate tendency to scarred narrowing has to be taken into account (Hosemann W, Th. Kuhnel, P. Held, W. Wagner, A. Felderhoff: Endonasal frontal sinusotomy in surgical management of chronic sinusitis—a critical evaluation. Am. J. Rhinology 11: 1-9 (1997)). In such cases it is advised to maximise the surgical access as a precaution. This “widened frontal sinus surgery” is subdivided into specific types (Draf W: Endonasal micro-endoscopic frontal sinus surgery: the Fulda concept. Op Tech Otolaryngol Head Neck Surg 2: 234-240 (1991); May M, Schaitkin B: Frontal sinus surgery: endonasal drainage instead of an external osteopolstic approach. Op Tech Otolaryngo Head Neck Surg 6: 184-192 (1995)).
  • As stated, the neo-ostium to the front sinus narrows to a greater or lesser extent, according to experience. To prevent this scarred stenosis it was already proposed at the start of the last century, i.e. long before the introduction of minimally invasive endoscopic surgery to insert a spacing device (stent). These spacing devices usually had the form of a small tube and were made of various materials: at the beginning rolled metal or metal braided in wires was used (Fletscher Ingals E: New operation and instruments for draining the frontal sinus. Ann Otol Rhinol Laryngol 14: 515-519 (1905), Good R H: An intranasal method for opening the frontal sinus establishing the largest possible drainage. Laryngoscope 18: 266-274 (1908)). In the last two decades silicone tubes were preferred (Stammberger H: Komplikationen entzundlicher Nasennebenhohlenerkrankungen eischlie.beta.lich iatrogen bedingter Komplikationen. Eur Arch Oto-Rhino-Laryngol Suppl 1993/1: 61-186).
  • Experience with spacing devices for stabilising the newly created frontal sinus access was not always, however, encouraging, apart from individual reports (Jacobs J B: 100 years of frontal sinus surgery. Laryngoscope 107: 1-36 (1997); Weber, R, W. Hosemann, W. Draf, R. Keerl, B. Schick, S. Schinzel: Denonasale Stirnhohlenchirugie mit Langzeiteinlage eines Platzhalters. Laryngol. Rhinol. Otol. 76: 728-734 (1997).
  • Initially it remained unclear as to how long a spacing device of this type was required in the area of the operation. From animal experiments on wound healing, it became clear that a scarred narrowing of the frontal sinus access for a post-operative period of at least three months has to be assumed (Hosemann, M. E. Wigand, U. Gode, F. Lnger, I. Dunker: Normal wound healing of the paranasal sinuses—clinical and experimental investigations, Eur. Arch, Otorhinolarylgol. 248: 390-394 (1991)). Accordingly, the spacing device would have to be used over eight to twelve weeks. Even with the correct duration in position a spacing device will often only delay and possibly reduce in scope the undesired scarred narrowing, without being able to prevent it completely. An additional medicinal treatment to reduce excessive wound reactions would have to take place here.
  • According to the present level of knowledge about wound healing processes in the nose the administration of medicinal substances such as, for example, corticosteroids, seems to be in a position to counteract, with a certain reliability, this tendency to regenerating mucous membrane for scarred stricture of the front sinus nose passage (Hosemann, M. E. Wigand, U. Gode, F. Lnger, I. Dunker: Normal wound healing of the paranasal sinuses—clinical and experimental investigations. Eur. Arch. Otorhinolaryngol. 248: 390-394 (1991); Hosemann W, Gode U, Langer F, Wigan M E: Experimentelle Untersuchungen zur Wundheilung in den Nasennebenhohlen. II. Spontaner Wundschluss und medikamentose Effekte im standardisierten Wundmodell. HNO 39″48-54 (1991); Hosemann W, Kuhnel Th, Allert M H. Weiterbehandlung nach Nasennebenhohleneingriffen, part 2: Theapeutische Maβnahmen, HNO aktuell 7: 291-302 (1999).
  • Unfortunately, conventional medicine forms such as salves or sprays do not reach into the problem region of the transition of frontal sinus and nose during routine application (Prince M E P, Lemckert R J: Analysis of the intranasal distribution of ointment. J Otolaryngol 26: 357-360 (1997); Weber R. Keerl R, Radziwill R, Schick B, Haspersen D, Dshambazov K, Mlynski G, Draf W: Videoendoscopic analysis of nasal steroid distribution. Rhinology 37: 69-73 (1999)).
  • Postoperative systemic administration of corticosteroids is certainly usual in rhinosurgery (Bumm P: Hals-Nasen-Ohrenkrankheiten. In: Kaiser H, Kley H K (Hrsg.) Cortizontherapie, Corticoide in Klinik und Praxis. Thieme, Stuttgart 1992, pages 390-401), but the treatment plans do not usually extend over the required duration of 8 weeks. Moreover, with longer-term systemic corticosteroid administration side effects of the treatment have to be increasingly taken into account.
  • The presently described problems show the need for systems which can in a controlled manner dispense the active substances such as, for example, corticosteroids over a longer period directly to the operation site.
  • A series of systems have been proposed for the controlled release of medicinal substances such as, for example implants of polymers loaded with a medicinal substance. U.S. Pat. No. 5,633,000 thus describes implants for the release of pain killers. The polymers used there release the active substance via diffusion. U.S. Pat. No. 5,019,372 describes that this release can be modulated by incorporation of magnetic particles and by application of alternating magnetic fields. If this formed body is designed with a correspondingly defined geometry the release of the active substances can be optimised such that they are released over the application period at a constant speed (U.S. Pat. No. 4,803,076).
  • The polymers used for such applications include, apart from biodegradable materials, non-biodegradable materials, i.e. those which do not decompose on contact with body fluids. Examples of such polymers are silicone, polyacrylate and ethylene vinyl acetate copolymer (U.S. Pat. No. 4,069,307). The last polymer group, in particular, was used for a series of systems for controlled release of active substances.
  • U.S. Pat. No. 3,393,073 thus describes a so-called reservoir system consisting of a medicinal substance reservoir which is surrounded by a polymer sheath regulating the release rate of the medicinal substance. Such systems were successfully used for the development of “intra-uterine devices” which release the active substance in the uterus (U.S. Pat. No. 3,967,618 and U.S. Pat. No. 4,016,251) and for producing therapeutic systems which release medicinal substances to the eye (U.S. Pat. No. 4,052,505).
  • Such systems were also described, as carrier systems with a microporous membrane controlling the discharge of the active substance, for introduction into various body cavities, such as for example, the ear, nose or the rectum (U.S. Pat. No. 3,948,254).
  • Those made of plastics are described in the area of “stents” for the treatment of paranasal sinuses, such as, for example in U.S. Pat. No. 5,693,065 or U.S. Pat. No. 5,336,163. U.S. Pat. No. 5,693,065 describes a stent for the nose area made of silicone rubber having a cylindrical shaft of which the leading end to be inserted into the nose is designed in the shape of the point of a spear, the base of the point connected to the shaft having a wider diameter than the shaft. The point is closed at the front and laterally has ribs with slits therebetween, the ribs expanding in the inserted state and thus ensuring the hold of the stent in the nose area.
  • An external diameter of 0.157 inches and an internal diameter of 0.118 inches is given as the dimensions for the shaft. The firm seat of the stent in the nose passage is only ensured, however, by the spreading of the spear-shaped point.
  • U.S. Pat. No. 5,336,163 relates to a stent for the nose area formed from a porous material and having a non-adhering, but slightly porous outer surface. The stent is formed from a material here which expands on contact with liquid.
  • U.S. Pat. No. 5,601,594 describes a stent for insertion into a nose aperture, the stent having a bent shape and being formed from a compressible material.
  • However, these are systems which are free of medicinal substances and the action of which only aims to keep open the accesses to the frontal sinus by physical/mechanical effects.
  • Despite this progress in the area of controlled release of active substances there has previously not been any indications that this technology could be usable for the post-operative care of sinus systems after minimally invasive clearing. Although so-called “stents” which prevent a tissue reconstruction are known these are described exclusively for the treatment of blood vessels and are accordingly geared to other biological needs.
  • U.S. Pat. No. 5,980,551 describes a stent for blood vessels, the stent having an inner support structure which may be formed from a wire and the support structure is surrounded by a biodegradable resorbable substrate. Biologically active microparticles which release active substances in a controlled manner can be embedded into this substrate.
  • Stents for suppressing the restenosis of coronary arteries have design features which clearly differ from the subject of the invention and therefore also make them unsuitable for application in the frontal sinus.
  • In many cases the “coronary stents” also require application aids. Such application aids are described in combination with a stent in U.S. Pat. No. 6,080,190 and U.S. Pat. No. 5,843,089. A serious problem of coronary stents to release active substances is the construction of the medicinal substance release system. Coronary stents generally consist of a stent body such as, for example, a wire braiding covered with medicinal substance-carrying polymers or sheathed in thin polymer films (U.S. Pat. No. 5,824,048, U.S. Pat. No. 5,700,286, U.S. Pat. No. 5,837,313, U.S. Pat. No. 5,679,400). The mechanical stability of these stents is geared to the needs of arteries and makes them unsuitable for application in the nasal sinus, as they are not mechanically stable enough.
  • Coronary stents are rotationally symmetrical hollow bodies and preferably have the geometry of a hollow cylinder. They can therefore not be fixed via thickenings at the cylinder end in a fenestration of the paranasal sinus. Moreover, a fenestration of the paranasal sinus is generally not uniformly round, but more or less irregular which creates additional problems with respect to anchoring. In general, coronary stents cannot have large wall thicknesses so as not to impede the blood flow.
  • Moreover, coronary stents differ from spacing devices for paranasal sinuses due to their function. The coronary stent is intended to expand the vessel in many cases. The front sinus spacing device, on the other hand, is inserted in a surgically applied passage which has bony (stable) walls. This passage was surgically newly formed; the coronary artery, on the other hand is left as a tube, but expanded.
  • A coronary stent is a permanent implant, it is completely absorbed by the body. The frontal sinus spacing device, on the other hand, is removed after a period of about 8 weeks.
  • The coronary stent is completely absorbed by the body. Blood flows in the interior of the coronary stent; the wall is completely colonised in the most favourable case by the body's own cells (endothelial cells). With the frontal sinus spacing device, complete absorption into the body is not desirable. Secretion from the mucous membrane surface should drain in the interior of the frontal sinus spacing device and ventilation should simultaneously be ensured. Colonisation of the interior of the spacing device with the body's own cells is neither anticipated nor desired.
  • On the other hand, the mucous membrane should widen at the outside of the frontal sinus spacing device. In this manner, once the spacing device has been removed, a passage lined with intact mucous membrane should remain.
  • A problem in the coronary stent is the formation of a clot with the risk of an occlusion which has to be suppressed by the administration of special medication. The frontal sinus spacing device does not require the administration of special medication.
  • It has been proposed to produce medical devices used in the body from a material loaded with active substance or to coat them therewith.
  • WO 96/29071 describes medical devices such as catheters or stents, on the surface of which antibacterial means are applied, the antibacterial means adhering to the surface owing to adhesive forces, without further aids being required.
  • It is proposed in general in WO 92/15286 to form medical devices from a polymer loaded with medicinal substance or to provide them with a coating thereof, stents also being mentioned for use in the nasal area, without more detail about the configuration of a stent of this type.
  • It was the object of the invention to provide a spacing device suitable, in particular, for use in the paranasal sinus having not only adequate stability and a firm hold but simultaneously able to release in situ a desired active substance in a controlled manner, a controlled release of the required amount of active substance with the desired time course also being ensured over an adequately long period for the treatment.
  • In addition, the spacing device according to the invention allows an adequately large quantity of active substance to be received and stored, without impairment of the controlled release owing to interactions of the active substance contents.
  • According to the invention, this object is achieved by a spacing device as described in the independent claims 1 and 2. Advantageous developments are the subject of the sub-claims.
  • To do justice to the above-mentioned requirements the ratio q of the external diameter ra to the internal diameter ri of the stent body is a value of 1.2 and more.
  • According to the invention the ratio q is selected in a range of 1.2≦q≦3.0, in particular of 1.2≦q≦2.8, preferably of 1.5≦q≦2.5 and particularly preferably 1.8≦q≦2.2.
  • In contrast to this, for coronary stents the value q is typically in a range of less than 1.2.
  • It has been shown, however, that with the smaller wall thicknesses of the coronary stent in comparison to the stent according to the invention for the paranasal sinus, the controlled release of active substance as desired according to the invention cannot be achieved.
  • The quotient q can thus serve as the calculation basis here. For example, for a hollow cylinder the volume V can be calculated from the height h, the internal diameter ri and q:

  • V=π·h·r i 2(q 2−1)  [1]
  • Formula I makes it clear that the volume of a coronary stent (with q=1.2), with the same internal diameter ri and the same height h is a maximum of about 15% of the volume of a paranasal sinus spacing device according to the invention (with q=2). It follows from this that stents with q=1.2 or less can receive a maximum of 1/7 of the active substance dose of a paranasal sinus spacing device according to the invention.
  • The quotient q has serious consequences for the release periods over which active substances can be released. To estimate the release duration t as a function of the thickness of a material I and the diffusion coefficients D, in the literature the dimensionless expression:
  • t = I 2 D [ 2 ]
  • is used (Cussler, E. L.; Diffusion: Mass Transfer in Fluid Systems, Cambridge Univ. Press, 1996). The diffusion section in a hollow cylinder can be estimated as half the difference between external diameter ra and external diameter ri. In a stent with a constant internal diameter ri the release duration is reduced to 4% when q is reduced from 2 to 1.2. For the above-mentioned reasons, for the described paranasal sinus spacing device the value q is preferably above 1.2 and in particular in a range 1.2≦q≦2.8, particularly preferably 1.5≦q≦2.5 and particularly preferably the range is 1.8≦q≦2.2.
  • According to a further aspect, the invention relates to a spacing device for the paranasal sinus in which the layer or layers loaded with active substance are separated towards the inner cavity by a layer consisting of a material which is impermeable or at least virtually impermeable for the active substance. Active substance losses are thus avoided and the duration over which the active substance is released is simultaneously increased.
  • Serious differences also exist with respect to the mechanical properties. Coronary stents which are introduced via a catheter into the blood vessels have to be plastically, i.e. irreversibly deformable. Owing to an irreversible widening of the stent, they have to be fixed to the vessel wall.
  • The spacing device developed in the course of this invention for use in the paranasal sinus, in contrast thereto, is distinguished by elastic properties and therefore reversible deformability; the paranasal sinus spacing device can be fixed simply in the apertures to the paranasal sinus, inter alia owing to this elasticity.
  • It is possible with the spacing device (stent) loaded with active substance according to the invention to keep the frontal sinus accesses open not only by a physical/mechanical mechanism, but also by a pharmacological mechanism. These spacing devices are adapted to the surgically created accesses to the paranasal sinus and fulfil two functions:
  • 1. They keep physically open the newly created “fenestration” of the front sinus in the course of the minimally invasive clearing. On the one hand, this is achieved by the application of the spacing device to the surgically changed tissue and assisted by the encouragement of the secretion drainage from the sinus.
  • 2. The developed spacing devices may release active substances such as medicinal substances such as, for example corticosteroids which suppress tissue formation or overshooting wound healing and therefore keep open the surgically newly created fenestration.
  • In order to be able to fulfil both functions in an optimal manner, the “stent” has some design features which will be described in more detail hereinafter with the aid of the figures.
  • The spacing device according to the invention is a hollow body which is composed of a sheath surrounding an inner cavity and having a respective aperture at two opposing ends.
  • The hollow body is preferably based on a cylindrical shape wherein it can deviate from the ideal cylindrical form with an in particular uniform diameter along the shaft.
  • The external diameter along the cylinder shaft may thus vary, for example the external diameter in the end regions close to the apertures may be selected to be larger than in the central shaft region.
  • Starting from the end regions, the external diameter may continuously reduce in the direction of the central shaft region, may be reduced in the manner of an hourglass in the central region, wherein the specific shape of the cylindrical basic body can be adapted in any way as necessary.
  • The wall thickness of the cylinder may also be selected to be variable.
  • Thus, in the drawings:
  • FIG. 1 shows a preferred configuration according to the invention of the spacing device in cylindrical form,
  • FIG. 2 shows the top view of a cross-section through a spacing device loaded with active substance according to the invention,
  • FIG. 3 shows the top view of a cross-section of another preferred configuration of the spacing device according to the invention as a reservoir system with a plurality of layers,
  • FIG. 4 shows a further configuration of the spacing device according to the invention with perforations in the sheath,
  • FIG. 5 shows a configuration of the spacing device according to the invention, wherein the external diameter of the cylindrical shaft in the end regions is greater than towards the centre and furthermore the wall thickness increases towards the centre of the cylinder shaft,
  • FIG. 6 shows a further configuration of the spacing device according to the invention as a matrix system with a plurality of layers, and
  • FIG. 7 is a graph with the release curve of an active substance from a preferred layer material according to the invention.
  • The geometry of the spacing device is preferably that of a hollow cylinder as can be seen in FIG. 1, wherein a sheath 1 surrounds an inner cavity having apertures 2 at the two opposing ends of the cylinder shaft. This cylinder form encourages the secretion drainage from the sinuses owing to its tubular design.
  • The length of the cylinder is preferably selected here in a range of 5 to 30 mm and its external diameter in a range of 1 to 30 mm. The wall thickness is to be selected according to need as a function of the physical properties of the polymer materials used and the active substances used and the desired release profile within the above-mentioned ranges for the ratio q of external diameter to internal diameter.
  • The at least two inner apertures 2 typically have a diameter in a range of 0.5 to 25 mm.
  • FIG. 2 shows an example of a spacing device with a monolithic construction, wherein the sheath 1 is composed of a single layer and the layer material forms the matrix for the active substance.
  • FIG. 3 shows an example of a configuration of the spacing device according to the invention as a reservoir system, wherein the active substance is contained in a reservoir 4. In this case the active substance is not contained in a matrix material, unlike in the matrix system. The active substance may here directly form the layer forming the reservoir or the active substance may be provided in a corresponding cavity. The latter case is suitable in particular for liquid or semi-solid active substances or for liquid or semi-solid carriers containing the active substance. The active substance to be released may also be dissolved or suspended in the reservoir system.
  • The release-controlling material forming the cavity, for example a reservoir 4 is surrounded by an outer membrane 3 which preferably consists of a polymer material through which the active substance can diffuse.
  • The cavity forming the reservoir 4 is preferably separated on the inside to the inner cavity 3 by an inner wall 4 preferably consisting of a material which is impermeable or virtually impermeable to the active substance.
  • An inner layer (inner wall 4) which is as impermeable as possible to the active substance is suitable in principle for any active substance-carrying systems for avoiding active substance losses in the direction of the inner cavity 3.
  • The inner wall 4 may consist here of a corresponding polymer material but also of an inorganic material such as a metal etc.
  • The sheath 1 may have perforations 7, as shown in FIG. 4, which connect the inner cavity 3 to the outer surface of the stent. The secretion drainage can also be assisted by this measure.
  • The form and number of perforations 7 can be freely selected here as required.
  • A configuration according to the invention with a varying external diameter is shown in FIG. 5. In the embodiment shown in FIG. 5, the external diameter of the stent is selected to be greater at the end regions with the apertures 2 than in the central region and decreases continuously towards the centre.
  • As shown here, the wall thickness may also vary, wherein it decreases in this case towards the end regions.
  • The wall thickness, in other words the ratio q of external diameter to internal diameter may, as required, in particular in the end regions or else in short central sections be outside the value to be adjusted according to the invention for q, if the usability of the stent is not impaired. Thus, at least in the wound regions q should be within the above-mentioned value range according to the invention of 1.2≦q≦3.0. In the event that in individual regions of the hollow body the wall thickness has a value q outside the value range according to the invention, these regions or this range should not be more than 30% of the hollow body.
  • The stent according to the invention may be formed from one or more layers, wherein the layers may consist of the identical and/or different polymers. Individual regions of a layer, for example the end regions close to the apertures 2 may be manufactured from a material which is different from the material for the remaining layer regions. In other words one layer may contain at least one region which is formed from a different material than the remaining layer.
  • In addition, the stent according to the invention may have layers which are free of active substance in addition to layers which are loaded with active substance.
  • If necessary, the stent according to the invention may be surrounded by a suitable outer coating.
  • In contrast to coronary stents, the spacing device according to the invention does not necessarily lie homogenously and in a planar manner on the tissue. This circumstance requires a particular construction so that, for example, secretion cannot build up in the long term between the spacing device and the sinus wall. Secretion drainage can be facilitated by perforations 7 in the wall of the spacing device (see cross-section shown in FIG. 4). With respect to its form the spacing device may show an “hourglass-shaped”transition zone from the front sinus to the nasal interior (FIG. 5) and permits endoscopy of the sinus through a central aperture.
  • According to a further configuration, the space holder may have irregularities such as humps etc. on its outer surface. In this case, contact with the nasal wall is via these irregularities, wherein, on the one hand, the contact face can be reduced and an adequately firm hold is nevertheless ensured. The developing cavities between the outer surface of the stent and nasal wall simultaneously encourage secretion drainage.
  • The spacing device is moreover advantageously provided such that suction of the paranasal sinus remains possible owing to the spacing device. This is made possible owing to a relatively small length. The spacing device is therefore preferably constructed such that it can be cut to the desired length directly prior to application.
  • The spacing device must be “anchored” counter to gravity in the frontal sinus entry. This anchoring can be achieved by a “ballooning” of the implant, i.e. a widening of the spacing device end in the frontal sinus or fixing by means of a seam on the nasal septum. Moreover, the stent may consist of materials which favour anchoring and shape adaptation. In this context “shape memory polymers” (for example U.S. Pat. No. 5,139,832, U.S. Pat. No. 5,189,110) or swelling polymers can be used (for example DE 4 032 096).
  • While the former change their shape at body temperature, with swelling substances there is a volume increase of the material owing to water absorption and therefore an increase in the stent diameter after its application. The materials adapt optimally here to the defect and thus prevent slipping of the stent. Owing to their good permeability to water, swelling polymers prevent a build up of secretion at the contact face to the tissue.
  • An example of this is shown in FIG. 6, wherein the outer layer 9 consists of a deformable polymer and surrounds a polymer layer 8 loaded with active substance.
  • The spacing device in the nose, in contrast to spacing devices in vessels, is exposed to a bacteria-loaded environment (mucous membrane wounds with free contact to the outside air). Owing to corresponding shaping, scab formation and bacterial contamination is delayed. This may, for example, be achieved by an adequately large internal diameter of the spacing device encouraging secretion drainage. The materials used may moreover be modified at the surface in such a way that secretion drainage is encouraged and bacterial contamination is avoided. An example is the hydrophilising of the surface. For this purpose the interior of the hollow body can be lined with a polymer layer which is highly wettable and preferably has water contact angles <45°.
  • As an alternative thereto, polymers can be used, the surface of which has been chemically modified, such as, for example, by the chemical bonding of hydrophilic substances or by treatment with gas plasma.
  • To avoid any bacterial contamination the spacing device may also be loaded with bactericidally or bacteriostatically active substances.
  • In order to ensure the diverse functions of the stent, the design of the matrix system may above all consist of a plurality of polymer layers as the cross-section in FIG. 6 shows by way of example. The number of layers is not limited to 2 as shown in the figure. Thus a plurality of layers which fulfil different functions can be combined with one another. Individual layers may be free of medicinal substance or be loaded with one or more medicinal substances. In loading different layers with various medicinal substances, the latter may be released from the spacing device with different kinetics. The thickness of individual polymer layers may be thin, as desired, for example in the range of a few micrometres.
  • The spacing device may also be already preformed prior to application or else be shaped to its final geometry by processing a precursor. Methods, such as, for example, extrusion or injection moulding are excellently suited to producing preformed spacing devices. For production from precursors polymer films may for example be rolled to form hollow bodies and fixed by a seam.
  • The materials from which the spacing device can be produced may be biodegradable or else non-biodegradable materials or a combination thereof.
  • Examples of possible biodegradable materials are polymers of lactic acid or glycolic acid and their copolymers. Further suitable examples are to be found in the literature (K. Park, W. S. W. Shalaby, H. Park, Biodegradable Hydrogels for Medicinal substance Delivery, Technomic Publishing Inc. Lancaster 1993; A. Domb, J. Kost, D. M. Wiseman, Handbook of Biodegradable Polymers, Harwood Academic Publishers, 1997).
  • While biodegradable materials have the advantage of not having to be removed after application, non-biodegradable materials can be better fixed in the region of use of the spacing device. Examples of such materials are silicones, polyacrylates and polymethacrylates and the copolymers thereof (Eudragit®)), poly(ethylene vinyl acetate) copolymer and other compositions as described in the polymer literature and known for medical applications.
  • The polymers should preferably be flexible so that they adapt to the wound area. Moreover, they should be elastic enough to remain in the fenestration and should be biocompatible, in other words have good tolerability with respect to cells and tissues. To ensure the mechanical adherence of the spacing device to the fenestration, the polymers mentioned can be combined with other materials, such as for example metals to ensure a reliable seat of the “stent” with smaller wall thicknesses. These metals can be incorporated into the wall of the cylinder.
  • The polymers can be processed by various industrial methods to form the spacing devices shown in FIGS. 1 and 2, thus, for example by extrusion or injection moulding or by polymerisation in suitable moulds.
  • The casting of polymer solutions is a simple production method (solvent casting). For this purpose the polymers are dissolved in organic solvents and the solution is poured or sprayed onto an inert surface. After evaporation of the solvent dry polymer films loaded with active substance are obtained which can be cut into any, for example rectangular forms.
  • While tubes are directly obtained by extrusion or injection moulding, small individually adapted tubes can be formed from rectangular polymer films directly before insertion into the patient. This may take place by repeated rolling of the polymer film or by mechanical adhesion or sticking of opposing film edges.
  • Owing to the type of production, the polymer properties can be controlled such that either smooth or porous surfaces are produced. This influences the rate of active substance administration and optionally the interaction between the spacing device and wound edges.
  • The surfaces of the spacing device towards the tissue and the secretion side may also be changed such that they optimally do justice to the requirements of their functions. The inside of the cylinder to the cavity of the spacing device may, for example be physico-chemically changed on its surface such that there can be improved wetting with secretion and therefore improved secretion drainage. Examples are the above-mentioned hydrophilising of surfaces or the covalent bonding of hydrophilic substances to the polymer surfaces.
  • The surface to the tissue side may be chemically changed such that the tissue compatibility is improved. This can be achieved by a coating with materials in the form of thin films or connection or application of functional groups or whole molecules which interact with the biological system. Thus the anchoring of polyethylene glycol chains to the surface leads to a reduced cell attachment and this facilitates the removal of the spacing device and increases it compatibility with the wound tissue.
  • The active substances can be selected according to need, application, desired property etc. They can also be used in combination. In particular, the stents according to the invention are loaded with medicinal substances.
  • Substances are generally used as medicinal substances which may influence the behaviour of cells and tissues, in particular they should prevent uncontrolled tissue growth. For this purpose, representatives of the group of glycocorticosteroids are suitable, such as for example cortisol, corisone, prednisone, prednisolone, 6-methylprednisolone, dexamethasone, fludrocortisone, desoxycorticoacetate. Further examples are proteins from the area of cytokines and growth factors which are also said to have some cell growth-inhibiting properties. Moreover, tyrosine kinase inhibitors, antisense-oligonucleotides and mitosis inhibitors such as mitomycin are suitable for eliminating the proliferative influence of growth factors during wound healing.
  • The active substances can be released from the spacing device over a long time period. Depending on the design and the material used, releases can be carried out for up to several years. Release preferably extends over a time period of 2 to 12 weeks. Principles controlling the release include, apart from the wall thickness expressed as the ratio q, primarily diffusion and polymer swelling for non-biodegradable polymers. When using biodegradable materials, i.e. those which dissolve during use, polymer erosion also plays an important part (Gopferich, Polymer Degradation and Erosion: Mechanismus and Applications, Eur. J. Pharm. Biopharm., 42 (1996) 1-11).
  • If the spacing device is produced from the preferred non-degradable materials, the active substance is preferably released from the reservoir or a matrix system. In both cases, the active substance is released in the process by diffusion. The release of active substance can be influence by a plurality of factors. By changing the geometry the active substance can be released over different lengths of time. Furthermore, it is possible to control the kinetics of the active substance release by the degree of loading.
  • The loading, in particular in the embodiment as a matrix system, is preferably in a range up to 30% by weight based on the total system. The minimum loading depends inter alia on the potency of the active substance and on the desired duration of release.
  • To further influence diffusion additives can be added to the polymer matrix or the polymers. Inert inorganic materials such as, for example silicone dioxide thus lead to a reduction in the rate of release. Depending on the type of polymer the rate of release can be increased by plasticiser additives. During polymer swelling, swelling can be increased by osmotic additives into the polymer and the rate of release can therefore be increased depending on the active substance properties.
  • To control the active substance release by erosion, the type of biodegradable polymer can be geared to the application. Thus, for example, it is known with poly(D,L-lactide-co-glycolide) that the rate of release and the rate of erosion can be controlled by the increase in the glycolide content.
  • The subject of the invention is a spacing device (stent) which after surgical opening of the paranasal sinus (mainly the frontal sinus) is inserted into the created fenestration to the nose. The newly developed spacing device prevents a post-operative scarred narrowing in that it combines two conventional treatment attempts for the surgically newly created frontal sinus access:
  • 1. The spacing device acts as a physical barrier which mechanically keeps the access to the frontal sinus open.
  • 2. The spacing device releases medicinal substances which control the growth of the tissue around the newly created access to the front sinus.
  • The material of the spacing device preferably has the mechanical properties of an elastomer such as, for example silicone, a proven material in ENT surgery for spacing devices. Owing to the preferred geometry which corresponds substantially to that of a hollow cylinder, secretion can drain from the sinuses. Moreover, the material acts as a local release system for medicinal substances such as for example corticosteroids. Owing to the shape and function the stent ensures a firm seat and simultaneously allows optimum secretion drainage. The continuous release of a defined quantity of medicinal substance is preferably ensured over a period of 8 weeks. The anticipated duration in position of the implant is preferably also 8 weeks. For production, films loaded with medicinal material, for example, can be rolled to form a cylinder and stabilised with a surgical seam. The spacing device is inserted intra operationem into the newly created frontal sinus access. If necessary, it is fixed in the operation area by its particular form, the materials used, its construction and/or by a surgical seam to prevent displacement. Apart from the use in fenestrations to the paranasal sinus, use is possible in the middle ear and the trachea.
  • EXAMPLE
  • Production of a Dexamethasone-Loaded Polymer Film
  • The film has the following composition:
  • Evatane 40-55 (purified with acetone) 17.955 g
    Dexamethasone DAB
    10/Ph. Eur. 0.045 g
    Dichloromethane p.A. 98 ml
    Acetone p.A. 4.5 ml
  • The polymer used, a poly(ethylene-vinyl acetate) copolymer is initially freed of additives which were added during the production of Evatane 40-55. 50 g of Evatane 40-55 are also weighed out into a 500 ml iodine measuring cylinder with a magnetic stirring rod. 250 ml acetone p.a. are measured with a measuring cylinder and added to the polymer. The batch is stirred on the magnetic stirrer for about a week and the acetone is then decanted. The polymer is washed 3 times with 80 ml acetone p.a. and the washing liquid discarded. The extraction and washing procedure is repeated once with acetone and twice with ethanol using the same volumes. The polymer is then dried in a crystallising dish in a laminar airflow box for 48 h and then in a desiccator under vacuum.
  • 17.955 g Evatane 40-55 are then weighed out into a 250 ml iodine value vessel. The dichloromethane is added thereto and stirred on the magnetic stirrer over 12 h. The dexamethasone is dissolved in acetone and added to the polymer solution. The batch is then left to stand for 10 min without stirring to remove air bubbles. The solution is poured into a planar Teflon mould with an area of 15 cm2 and dried in a laminar airflow box over 4 days.
  • The dried film is drawn from the Teflon mould and cut into pieces of any size. The film thickness is about 0.8 to 1 mm. The polymer films are rolled to form a hollow cylinder and preferably fixed by a seam with a biocompatible seam material at the contact points in such a way that the cylinder does not unwind owing to the elasticity of the material. The small tube formed in this way is then inserted into the fenestration to the paranasal sinus.
  • EXAMPLE Release of Dexamethasone from the Polymer Film in Example 1
  • Round pieces with a diameter of 1.2 cm in diameter were cut from the film described in Example 1 and the release determined in vitro. The polymer platelets loaded with 0.25% dexamethasone were also stored in closable glass vessels in 10 ml phosphate buffer at 37° C. Samples were removed from the batch at regular intervals and replaced by fresh buffer. The dexamethasone content was determined per HPLC. FIG. 7 shows the release of dexamethasone over the time.
  • LIST OF REFERENCE NUMERALS
      • 1 sheath
      • 2 aperture
      • 3 inner cavity
      • 4 reservoir area
      • 5 membrane
      • 6 layer impermeable to active substance
      • 7 perforation
      • 8 polymer layer loaded with active substance
      • 9 deformable polymer layer

Claims (10)

1. A method for treating a disorder that affects a paranasal sinus, middle ear or trachea, said method comprising the steps of:
A) providing a substance delivering device that is implantable in an opening of a paranasal sinus, middle ear or trachea, said device comprising a tubular body having a wall, a lumen, first and second open ends, an outer surface, an inner surface and a substance containing layer, the substance containing layer comprising a matrix that contains therapeutic substance such that a therapeutically effective amount of the substance will elute from the device while implanted, wherein said therapeutic substance comprises at least one steroid; and
B) implanting the device in an opening of a paranasal sinus, middle ear or trachea such that a therapeutic amount of the therapeutic substance is delivered to the paranasal sinus, middle ear or trachea in which the device is implanted.
2. A method according to claim 1 wherein Step B comprises implanting the device in an opening of a paranasal sinus.
3. A method according to claim 1 wherein Step B comprises implanting the device in an opening of a frontal sinus.
4. A method according to claim 1 wherein Step B comprises implanting the device in an opening of a paranasal sinus that has been dilated.
5. A method according to claim 1 wherein Step B comprises implanting the device in an opening of a paranasal sinus that has been surgically altered.
6. A method according to claim 5 wherein the device is implanted in a surgically created fenestration.
7. A method according to claim 1 wherein the device is capable of being radially expanded and wherein Step B comprises radially expanding the device at an intended site of implantation.
8. A method according to claim 7 wherein the device is radially expanded by inflating a balloon positioned within the device.
9. A method according to claim 1 further comprising the step of:
C) removing the device.
10. A method according to claim 9 wherein the device is removed approximately 2 to 12 weeks after implantation.
US12/138,364 2001-02-06 2008-06-12 Spacing devices for releasing active substances in the paranasal sinus Abandoned US20080243140A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/138,364 US20080243140A1 (en) 2001-02-06 2008-06-12 Spacing devices for releasing active substances in the paranasal sinus

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE10105592.7 2001-02-06
DE10105592A DE10105592A1 (en) 2001-02-06 2001-02-06 Placeholder for drug release in the frontal sinus
PCT/EP2002/001228 WO2002062269A1 (en) 2001-02-06 2002-02-06 Spacing device for releasing active substances in the paranasal sinus
US47088104A 2004-02-04 2004-02-04
US12/138,364 US20080243140A1 (en) 2001-02-06 2008-06-12 Spacing devices for releasing active substances in the paranasal sinus

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
PCT/EP2002/001228 Division WO2002062269A1 (en) 2001-02-06 2002-02-06 Spacing device for releasing active substances in the paranasal sinus
US47088104A Division 2001-02-06 2004-02-04

Publications (1)

Publication Number Publication Date
US20080243140A1 true US20080243140A1 (en) 2008-10-02

Family

ID=7673200

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/470,881 Expired - Lifetime US8740929B2 (en) 2001-02-06 2002-02-06 Spacing device for releasing active substances in the paranasal sinus
US12/138,364 Abandoned US20080243140A1 (en) 2001-02-06 2008-06-12 Spacing devices for releasing active substances in the paranasal sinus

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/470,881 Expired - Lifetime US8740929B2 (en) 2001-02-06 2002-02-06 Spacing device for releasing active substances in the paranasal sinus

Country Status (5)

Country Link
US (2) US8740929B2 (en)
EP (1) EP1357861B1 (en)
AT (1) ATE430534T1 (en)
DE (2) DE10105592A1 (en)
WO (1) WO2002062269A1 (en)

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050043706A1 (en) * 2003-03-14 2005-02-24 Eaton Donald J. Sinus delivery of sustained release therapeutics
US20100100170A1 (en) * 2008-10-22 2010-04-22 Boston Scientific Scimed, Inc. Shape memory tubular stent with grooves
US20110201996A1 (en) * 2008-08-27 2011-08-18 Melder Patrick C Nasal ventilation system and method of using same
US20110202037A1 (en) * 2008-08-18 2011-08-18 Bolger William E Fluid delivery catheter apparatus
US8025635B2 (en) 2005-04-04 2011-09-27 Intersect Ent, Inc. Device and methods for treating paranasal sinus conditions
US8435261B2 (en) 2009-07-15 2013-05-07 Regents Of The University Of Minnesota Treatment and placement device for sinusitis applications
US8535707B2 (en) 2006-07-10 2013-09-17 Intersect Ent, Inc. Devices and methods for delivering active agents to the osteomeatal complex
US8585731B2 (en) 2007-12-18 2013-11-19 Intersect Ent, Inc. Self-expanding devices and methods therefor
US8740929B2 (en) 2001-02-06 2014-06-03 Acclarent, Inc. Spacing device for releasing active substances in the paranasal sinus
US8763222B2 (en) 2008-08-01 2014-07-01 Intersect Ent, Inc. Methods and devices for crimping self-expanding devices
US8945142B2 (en) 2008-08-27 2015-02-03 Cook Medical Technologies Llc Delivery system for implanting nasal ventilation tube
US8998985B2 (en) 2011-07-25 2015-04-07 Rainbow Medical Ltd. Sinus stent
US9138569B2 (en) 2012-02-29 2015-09-22 SinuSys Corporation Devices and methods for dilating a paranasal sinus opening and for treating sinusitis
US9248266B2 (en) 2013-12-17 2016-02-02 Biovision Technologies, Llc Method of performing a sphenopalatine ganglion block procedure
US9498239B2 (en) 2010-08-30 2016-11-22 SinuSys Corporation Devices and methods for inserting a sinus dilator
US9516995B2 (en) 2013-12-17 2016-12-13 Biovision Technologies, Llc Surgical device for performing a sphenopalatine ganglion block procedure
US9687263B2 (en) 2013-05-30 2017-06-27 SinuSys Corporation Devices and methods for inserting a sinus dilator
US9694163B2 (en) 2013-12-17 2017-07-04 Biovision Technologies, Llc Surgical device for performing a sphenopalatine ganglion block procedure
US9956384B2 (en) 2014-01-24 2018-05-01 Cook Medical Technologies Llc Articulating balloon catheter and method for using the same
US10016580B2 (en) 2013-12-17 2018-07-10 Biovision Technologies, Llc Methods for treating sinus diseases
US10159586B2 (en) 2015-06-29 2018-12-25 480 Biomedical Inc. Scaffold loading and delivery systems
US10183153B2 (en) 2013-09-27 2019-01-22 Acclarent, Inc. Sinus wall implant
US10201639B2 (en) 2017-05-01 2019-02-12 480 Biomedical, Inc. Drug-eluting medical implants
US10232082B2 (en) 2015-06-29 2019-03-19 480 Biomedical, Inc. Implantable scaffolds for treatment of sinusitis
US10232152B2 (en) 2013-03-14 2019-03-19 Intersect Ent, Inc. Systems, devices, and method for treating a sinus condition
US10278812B2 (en) 2015-06-29 2019-05-07 480 Biomedical, Inc. Implantable scaffolds and methods for treatment of sinusitis
US10357640B2 (en) 2009-05-15 2019-07-23 Intersect Ent, Inc. Expandable devices and methods for treating a nasal or sinus condition
US10525240B1 (en) 2018-06-28 2020-01-07 Sandler Scientific LLC Sino-nasal rinse delivery device with agitation, flow-control and integrated medication management system
US10973664B2 (en) 2015-12-30 2021-04-13 Lyra Therapeutics, Inc. Scaffold loading and delivery systems

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE516858C2 (en) * 2000-07-25 2002-03-12 Entpro Hb Rinse nose and outlet for nose flushers
US8317816B2 (en) 2002-09-30 2012-11-27 Acclarent, Inc. Balloon catheters and methods for treating paranasal sinuses
US20040098090A1 (en) 2002-11-14 2004-05-20 Williams Michael S. Polymeric endoprosthesis and method of manufacture
JP2006506208A (en) * 2002-11-15 2006-02-23 サインコア,リミテッド・ライアビリティ・カンパニー Polymer endoprosthesis and method of manufacture
US7410480B2 (en) 2004-04-21 2008-08-12 Acclarent, Inc. Devices and methods for delivering therapeutic substances for the treatment of sinusitis and other disorders
US7559925B2 (en) 2006-09-15 2009-07-14 Acclarent Inc. Methods and devices for facilitating visualization in a surgical environment
US7803150B2 (en) 2004-04-21 2010-09-28 Acclarent, Inc. Devices, systems and methods useable for treating sinusitis
US9089258B2 (en) 2004-04-21 2015-07-28 Acclarent, Inc. Endoscopic methods and devices for transnasal procedures
US7419497B2 (en) 2004-04-21 2008-09-02 Acclarent, Inc. Methods for treating ethmoid disease
US7720521B2 (en) * 2004-04-21 2010-05-18 Acclarent, Inc. Methods and devices for performing procedures within the ear, nose, throat and paranasal sinuses
US20190314620A1 (en) 2004-04-21 2019-10-17 Acclarent, Inc. Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures
US20060004323A1 (en) 2004-04-21 2006-01-05 Exploramed Nc1, Inc. Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures
US7462175B2 (en) 2004-04-21 2008-12-09 Acclarent, Inc. Devices, systems and methods for treating disorders of the ear, nose and throat
US8702626B1 (en) 2004-04-21 2014-04-22 Acclarent, Inc. Guidewires for performing image guided procedures
US8932276B1 (en) 2004-04-21 2015-01-13 Acclarent, Inc. Shapeable guide catheters and related methods
US8894614B2 (en) 2004-04-21 2014-11-25 Acclarent, Inc. Devices, systems and methods useable for treating frontal sinusitis
US9101384B2 (en) 2004-04-21 2015-08-11 Acclarent, Inc. Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, Nose and/or throat
US10188413B1 (en) 2004-04-21 2019-01-29 Acclarent, Inc. Deflectable guide catheters and related methods
US20070167682A1 (en) 2004-04-21 2007-07-19 Acclarent, Inc. Endoscopic methods and devices for transnasal procedures
US7361168B2 (en) 2004-04-21 2008-04-22 Acclarent, Inc. Implantable device and methods for delivering drugs and other substances to treat sinusitis and other disorders
US8146400B2 (en) 2004-04-21 2012-04-03 Acclarent, Inc. Endoscopic methods and devices for transnasal procedures
US7654997B2 (en) 2004-04-21 2010-02-02 Acclarent, Inc. Devices, systems and methods for diagnosing and treating sinusitus and other disorders of the ears, nose and/or throat
US9399121B2 (en) 2004-04-21 2016-07-26 Acclarent, Inc. Systems and methods for transnasal dilation of passageways in the ear, nose or throat
US20060063973A1 (en) 2004-04-21 2006-03-23 Acclarent, Inc. Methods and apparatus for treating disorders of the ear, nose and throat
US8864787B2 (en) 2004-04-21 2014-10-21 Acclarent, Inc. Ethmoidotomy system and implantable spacer devices having therapeutic substance delivery capability for treatment of paranasal sinusitis
US9351750B2 (en) 2004-04-21 2016-05-31 Acclarent, Inc. Devices and methods for treating maxillary sinus disease
US20070208252A1 (en) 2004-04-21 2007-09-06 Acclarent, Inc. Systems and methods for performing image guided procedures within the ear, nose, throat and paranasal sinuses
US8764729B2 (en) 2004-04-21 2014-07-01 Acclarent, Inc. Frontal sinus spacer
US8747389B2 (en) 2004-04-21 2014-06-10 Acclarent, Inc. Systems for treating disorders of the ear, nose and throat
US9554691B2 (en) 2004-04-21 2017-01-31 Acclarent, Inc. Endoscopic methods and devices for transnasal procedures
US7055523B1 (en) * 2005-02-24 2006-06-06 Brown Thomas W Internal nasal dilator and delivery mechanism
US20070014830A1 (en) * 2005-06-08 2007-01-18 Tijsma Edze J Drug-releasing sinus stent
US8951225B2 (en) 2005-06-10 2015-02-10 Acclarent, Inc. Catheters with non-removable guide members useable for treatment of sinusitis
US8114113B2 (en) 2005-09-23 2012-02-14 Acclarent, Inc. Multi-conduit balloon catheter
US20070110788A1 (en) * 2005-11-14 2007-05-17 Hissong James B Injectable formulation capable of forming a drug-releasing device
US7959943B2 (en) * 2006-05-10 2011-06-14 Medtronics Xomed, Inc. Solvating system and sealant for medical use in the middle or inner ear
US7993675B2 (en) 2006-05-10 2011-08-09 Medtronic Xomed, Inc. Solvating system and sealant for medical use in the sinuses and nasal passages
US7976873B2 (en) * 2006-05-10 2011-07-12 Medtronic Xomed, Inc. Extracellular polysaccharide solvating system for treatment of bacterial ear conditions
US8190389B2 (en) 2006-05-17 2012-05-29 Acclarent, Inc. Adapter for attaching electromagnetic image guidance components to a medical device
US20070269385A1 (en) * 2006-05-18 2007-11-22 Mercator Medsystems, Inc Devices, methods, and systems for delivering therapeutic agents for the treatment of sinusitis, rhinitis, and other disorders
WO2007140079A2 (en) * 2006-05-23 2007-12-06 Entrigue Surgical, Inc. Sinus tube
US8313762B2 (en) 2006-07-05 2012-11-20 Medtronic Xomed, Inc. Flexible bioresorbable hemostatic packing and stent
US9173733B1 (en) * 2006-08-21 2015-11-03 Abbott Cardiovascular Systems Inc. Tracheobronchial implantable medical device and methods of use
US7547323B2 (en) * 2006-08-29 2009-06-16 Sinexus, Inc. Stent for irrigation and delivery of medication
US9820688B2 (en) 2006-09-15 2017-11-21 Acclarent, Inc. Sinus illumination lightwire device
US8439687B1 (en) 2006-12-29 2013-05-14 Acclarent, Inc. Apparatus and method for simulated insertion and positioning of guidewares and other interventional devices
US8088095B2 (en) * 2007-02-08 2012-01-03 Medtronic Xomed, Inc. Polymeric sealant for medical use
US8118757B2 (en) 2007-04-30 2012-02-21 Acclarent, Inc. Methods and devices for ostium measurement
US8485199B2 (en) 2007-05-08 2013-07-16 Acclarent, Inc. Methods and devices for protecting nasal turbinate during surgery
EP2182892B1 (en) * 2007-07-30 2020-08-12 Audubon Technologies, LLC Device for maintaining patent paranasal sinus ostia
US10206821B2 (en) 2007-12-20 2019-02-19 Acclarent, Inc. Eustachian tube dilation balloon with ventilation path
US8182432B2 (en) 2008-03-10 2012-05-22 Acclarent, Inc. Corewire design and construction for medical devices
ES2759373T3 (en) 2008-06-12 2020-05-08 Medtronic Xomed Inc Product for the treatment of chronic wounds with an extracellular system of solvation of polymeric substances
JP5676446B2 (en) 2008-07-30 2015-02-25 アクラレント インコーポレイテッド Sinus mouth finder
EP2323724A1 (en) 2008-09-18 2011-05-25 Acclarent, Inc. Methods and apparatus for treating disorders of the ear nose and throat
EP2389220A4 (en) * 2009-01-23 2017-09-13 Intersect ENT, Inc. Devices and methods for dilating tissues
US20100241155A1 (en) 2009-03-20 2010-09-23 Acclarent, Inc. Guide system with suction
US7978742B1 (en) 2010-03-24 2011-07-12 Corning Incorporated Methods for operating diode lasers
US8435290B2 (en) 2009-03-31 2013-05-07 Acclarent, Inc. System and method for treatment of non-ventilating middle ear by providing a gas pathway through the nasopharynx
WO2011008981A1 (en) * 2009-07-15 2011-01-20 Regents Of The University Of Minnesota Implantable devices for treatment of sinusitis
EP2477617B1 (en) 2009-09-18 2018-01-31 Bioinspire Technologies Inc. Free-standing biodegradable patch
US9271925B2 (en) 2013-03-11 2016-03-01 Bioinspire Technologies, Inc. Multi-layer biodegradable device having adjustable drug release profile
US9155492B2 (en) 2010-09-24 2015-10-13 Acclarent, Inc. Sinus illumination lightwire device
US9022967B2 (en) 2010-10-08 2015-05-05 Sinopsys Surgical, Inc. Implant device, tool, and methods relating to treatment of paranasal sinuses
US9095370B2 (en) 2011-06-29 2015-08-04 Cordis Corporation System and method for dilating and adjusting flexibility in a guiding device
WO2013009874A1 (en) * 2011-07-13 2013-01-17 The Foundry, Llc Delivery devices for nasopharyngeal mucosa targets
WO2013130464A1 (en) * 2012-02-29 2013-09-06 SinuSys Corporation Devices and methods for dilating a eustachian tube
US9572964B2 (en) 2012-04-11 2017-02-21 Sinapsys Surgical, Inc. Implantation tools, tool assemblies, kits and methods
US20140074065A1 (en) * 2012-09-07 2014-03-13 Acclarent, Inc. Bioabsorbable Spacers and Spacer Delivery Systems for Use in the Ear, Nose and Throat
USD745969S1 (en) * 2012-09-17 2015-12-22 Matheny Enterprises, Llc Nasal support device
KR102189608B1 (en) 2013-01-25 2020-12-11 사이놉시스 서지칼 인코포레이티드 Paranasal sinus access implant devices and related tools, methods and kits
US9433437B2 (en) 2013-03-15 2016-09-06 Acclarent, Inc. Apparatus and method for treatment of ethmoid sinusitis
US9629684B2 (en) 2013-03-15 2017-04-25 Acclarent, Inc. Apparatus and method for treatment of ethmoid sinusitis
CN105828755B (en) 2013-10-16 2019-01-22 西诺普西斯外科股份有限公司 Treatment-related equipment, tool, external member and method are manipulated with the fluid of nasal sinus
JP2017522122A (en) 2014-07-24 2017-08-10 シノプシス サージカル インコーポレイテッドSinopsys Surgical,Inc. Sinus access implant device and related products and methods
CA2996539A1 (en) * 2015-08-26 2017-03-02 Medtronic Xomed, Inc. Sinus and nasal stent
US10596330B2 (en) 2015-08-26 2020-03-24 Medtronic Xomed, Inc. Resorbable, drug-eluting submucosal turbinate implant device and method
WO2019023617A1 (en) 2017-07-27 2019-01-31 University Of Utah Research Foundation Therapeutic delivery device
CN111356422B (en) 2017-09-20 2022-08-09 西诺普西斯外科股份有限公司 Paranasal sinus fluid access implant tools, assemblies, kits and methods
CN111712269B (en) 2017-12-20 2022-06-28 史赛克欧洲运营有限责任公司 Biomedical foams
AU2019403377A1 (en) 2018-12-20 2021-07-08 Stryker European Operations Limited Skull base closure systems and methods
US20220168465A1 (en) * 2019-04-16 2022-06-02 Septum Solutions, Llc Biodegradable nasal splint

Citations (106)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US446173A (en) * 1891-02-10 Hasp and staple
US504424A (en) * 1893-09-05 Oscar de pezzer
US513667A (en) * 1894-01-30 Sliding staple for hasps
US705346A (en) * 1901-11-02 1902-07-22 Jonathan R Hamilton Dilator.
US798775A (en) * 1905-04-13 1905-09-05 Valorus A Bradbury Dispensing-bottle.
US816792A (en) * 1904-09-06 1906-04-03 Oliver H P Green Lock.
US2201749A (en) * 1939-02-15 1940-05-21 Vandegrift Middleton Expanding vein tube
US2493326A (en) * 1949-03-01 1950-01-03 John H Trinder Tampon for control of intractable nasal hemorrhages
US2847997A (en) * 1956-01-13 1958-08-19 James J Tibone Catheter
US2899227A (en) * 1959-08-11 Charles-louis gschwend
US2906179A (en) * 1957-01-28 1959-09-29 North American Aviation Inc Vector gage
US2995832A (en) * 1960-08-01 1961-08-15 Alderson Res Lab Inc Training aid for intravenous therapy
US3037286A (en) * 1957-01-28 1962-06-05 North American Aviation Inc Vector gage
US3173418A (en) * 1961-01-10 1965-03-16 Ostap E Baran Double-wall endotracheal cuff
US3376659A (en) * 1965-06-09 1968-04-09 Bard Inc C R Demonstration device
US3384970A (en) * 1965-09-22 1968-05-28 Boice Gages Inc Precision coordinates measurement apparatus for gaging and layout operations
US3393073A (en) * 1965-04-16 1968-07-16 Eastman Kodak Co High contrast photographic emulsions
US3435826A (en) * 1964-05-27 1969-04-01 Edwards Lab Inc Embolectomy catheter
US3506005A (en) * 1967-02-23 1970-04-14 Arthur S Gilio Pressure infusion device for medical use
US3509638A (en) * 1966-08-04 1970-05-05 Midland Ross Corp Treating apparatus
US3515888A (en) * 1967-10-27 1970-06-02 California Computer Products Manual optical digitizer
US3552384A (en) * 1967-07-03 1971-01-05 American Hospital Supply Corp Controllable tip guide body and catheter
US3731963A (en) * 1971-04-20 1973-05-08 R Pond Electrically actuated lock mechanism
US3792391A (en) * 1972-12-18 1974-02-12 L Ewing Electrically operated two position electromechanical mechanism
US3800788A (en) * 1972-07-12 1974-04-02 N White Antral catheter for reduction of fractures
US3802096A (en) * 1971-08-09 1974-04-09 H Matern Composite model for medical study
US3804081A (en) * 1971-07-29 1974-04-16 Olympus Optical Co Endoscope
US3859993A (en) * 1973-08-27 1975-01-14 Daniel G Bitner Operating table accessory
US3871365A (en) * 1972-06-19 1975-03-18 Machida Endoscope Co Ltd Endoscope
US3894538A (en) * 1972-08-10 1975-07-15 Siemens Ag Device for supplying medicines
US3948262A (en) * 1969-04-01 1976-04-06 Alza Corporation Novel drug delivery device
US3948254A (en) * 1971-11-08 1976-04-06 Alza Corporation Novel drug delivery device
US3967618A (en) * 1969-04-01 1976-07-06 Alza Corporation Drug delivery device
US4016251A (en) * 1972-08-17 1977-04-05 Alza Corporation Vaginal drug dispensing device
US4069307A (en) * 1970-10-01 1978-01-17 Alza Corporation Drug-delivery device comprising certain polymeric materials for controlled release of drug
US4102342A (en) * 1975-12-29 1978-07-25 Taichiro Akiyama Valved device
US4138151A (en) * 1976-07-30 1979-02-06 Olympus Optical Company Limited Detent device for locking the lid of a cassette receiving compartment of a tape recorder
US4184497A (en) * 1977-08-26 1980-01-22 University Of Utah Peritoneal dialysis catheter
US4198766A (en) * 1978-06-21 1980-04-22 Baxter Travenol Laboratories, Inc. Intravenous training/demonstration aid
US4207890A (en) * 1977-01-04 1980-06-17 Mcneilab, Inc. Drug-dispensing device and method
US4209919A (en) * 1977-07-23 1980-07-01 Taichiro Akiyama Model of living body
US4213095A (en) * 1978-08-04 1980-07-15 Bell Telephone Laboratories, Incorporated Feedforward nonlinear equalization of modulated data signals
US4217898A (en) * 1978-10-23 1980-08-19 Alza Corporation System with microporous reservoir having surface for diffusional delivery of agent
US4249531A (en) * 1979-07-05 1981-02-10 Alza Corporation Bioerodible system for delivering drug manufactured from poly(carboxylic acid)
US4268115A (en) * 1979-06-01 1981-05-19 Tetra-Tech, Inc. Quick-release fiber-optic connector
US4338941A (en) * 1980-09-10 1982-07-13 Payton Hugh W Apparatus for arresting posterior nosebleeds
US4388941A (en) * 1980-11-06 1983-06-21 Danfoss A/S Apparatus for producing a rotary speed-dependent control pressure
US4435716A (en) * 1981-09-14 1984-03-06 Adrian Zandbergen Method of making a conical spiral antenna
US4437856A (en) * 1981-02-09 1984-03-20 Alberto Valli Peritoneal catheter device for dialysis
US4450150A (en) * 1973-05-17 1984-05-22 Arthur D. Little, Inc. Biodegradable, implantable drug delivery depots, and method for preparing and using the same
US4459977A (en) * 1981-03-27 1984-07-17 Veronique Pizon Coronary sinus retroperfusion apparatus for the treatment of myocardial ischemia
US4464175A (en) * 1982-08-25 1984-08-07 Altman Alan R Multipurpose tamponade and thrombosclerotherapy tube
US4499899A (en) * 1983-01-21 1985-02-19 Brimfield Precision, Inc. Fiber-optic illuminated microsurgical scissors
US4564364A (en) * 1983-05-26 1986-01-14 Alza Corporation Active agent dispenser
US4571239A (en) * 1982-03-01 1986-02-18 Heyman Arnold M Catheter-stylet assembly for slipover urethral instruments
US4571240A (en) * 1983-08-12 1986-02-18 Advanced Cardiovascular Systems, Inc. Catheter having encapsulated tip marker
US4581017A (en) * 1983-03-07 1986-04-08 Harvinder Sahota Catheter systems
US4585000A (en) * 1983-09-28 1986-04-29 Cordis Corporation Expandable device for treating intravascular stenosis
US4589868A (en) * 1984-03-12 1986-05-20 Dretler Stephen P Expandable dilator-catheter
US4596528A (en) * 1984-07-02 1986-06-24 Lewis Leonard A Simulated skin and method
US4603564A (en) * 1981-06-17 1986-08-05 Bauer Kaba Ag Lock cylinder with integrated electromagnetic locking system
US4606346A (en) * 1984-01-11 1986-08-19 Olle Berg Intranasal device
US4607622A (en) * 1985-04-11 1986-08-26 Charles D. Fritch Fiber optic ocular endoscope
US4637389A (en) * 1985-04-08 1987-01-20 Heyden Eugene L Tubular device for intubation
US4639244A (en) * 1983-05-03 1987-01-27 Nabil I. Rizk Implantable electrophoretic pump for ionic drugs and associated methods
US4645495A (en) * 1985-06-26 1987-02-24 Vaillancourt Vincent L Vascular access implant needle patch
US4669469A (en) * 1986-02-28 1987-06-02 Devices For Vascular Intervention Single lumen atherectomy catheter device
US4672961A (en) * 1986-05-19 1987-06-16 Davies David H Retrolasing catheter and method
US4675613A (en) * 1983-08-11 1987-06-23 Hewlett-Packard Company Noise compensated synchronous detector system
US4726772A (en) * 1986-12-01 1988-02-23 Kurt Amplatz Medical simulator
US4736970A (en) * 1987-03-09 1988-04-12 Mcgourty Thomas K Electrically controlled door lock
US4737141A (en) * 1983-07-26 1988-04-12 Fundatech S.A. Method of draining the maxillary sinus for the treatment of maxillary sinusitis
US4748986A (en) * 1985-11-26 1988-06-07 Advanced Cardiovascular Systems, Inc. Floppy guide wire with opaque tip
US4748969A (en) * 1987-05-07 1988-06-07 Circon Corporation Multi-lumen core deflecting endoscope
US4748869A (en) * 1979-08-14 1988-06-07 Nissan Motor Company, Limited Automatic transmission for an automotive vehicle
US4755171A (en) * 1987-05-29 1988-07-05 Tennant Jerald L Tubular surgical device
US4795439A (en) * 1986-06-06 1989-01-03 Edward Weck Incorporated Spiral multi-lumen catheter
US4796629A (en) * 1987-06-03 1989-01-10 Joseph Grayzel Stiffened dilation balloon catheter device
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
US4811743A (en) * 1987-04-21 1989-03-14 Cordis Corporation Catheter guidewire
US4815478A (en) * 1987-02-17 1989-03-28 Medtronic Versaflex, Inc. Steerable guidewire with deflectable tip
US4819619A (en) * 1987-01-16 1989-04-11 Augustine Scott D Device for inserting a nasal tube
US4847258A (en) * 1986-08-26 1989-07-11 Ciba-Geigy Corporation Substituted benzoylphenylureas compounds useful as pesticides
US4846186A (en) * 1988-01-12 1989-07-11 Cordis Corporation Flexible guidewire
US4851228A (en) * 1984-06-20 1989-07-25 Merck & Co., Inc. Multiparticulate controlled porosity osmotic
US4854330A (en) * 1986-07-10 1989-08-08 Medrad, Inc. Formed core catheter guide wire assembly
US4897651A (en) * 1985-10-15 1990-01-30 Ing. C. Olivetti & C., S.P.A. Key with selective symbol display and keyboard using such key
US4898577A (en) * 1988-09-28 1990-02-06 Advanced Cardiovascular Systems, Inc. Guiding cathether with controllable distal tip
US4917419A (en) * 1988-08-22 1990-04-17 Mora Jr Saturnino F Electromechanical door lock system
US4917667A (en) * 1988-02-11 1990-04-17 Retroperfusion Systems, Inc. Retroperfusion balloon catheter and method
US4919112A (en) * 1989-04-07 1990-04-24 Schott Fiber Optics Low-cost semi-disposable endoscope
US4920967A (en) * 1986-07-18 1990-05-01 Pfizer Hospital Products Group, Inc. Doppler tip wire guide
US4925445A (en) * 1983-09-16 1990-05-15 Fuji Terumo Co., Ltd. Guide wire for catheter
US4940062A (en) * 1988-05-26 1990-07-10 Advanced Cardiovascular Systems, Inc. Guiding member with deflectable tip
US4943275A (en) * 1988-10-14 1990-07-24 Abiomed Limited Partnership Insertable balloon with curved support
WO1992015286A1 (en) * 1991-02-27 1992-09-17 Nova Pharmaceutical Corporation Anti-infective and anti-inflammatory releasing systems for medical devices
US5195984A (en) * 1988-10-04 1993-03-23 Expandable Grafts Partnership Expandable intraluminal graft
US5211952A (en) * 1991-04-12 1993-05-18 University Of Southern California Contraceptive methods and formulations for use therein
US5234456A (en) * 1990-02-08 1993-08-10 Pfizer Hospital Products Group, Inc. Hydrophilic stent
US5246455A (en) * 1991-05-17 1993-09-21 Micromedics, Inc. Middle meatal antrostomy ventilation tube
US5376376A (en) * 1992-01-13 1994-12-27 Li; Shu-Tung Resorbable vascular wound dressings
US5443458A (en) * 1992-12-22 1995-08-22 Advanced Cardiovascular Systems, Inc. Multilayered biodegradable stent and method of manufacture
US5693065A (en) * 1996-06-25 1997-12-02 Rains, Iii; B. Manrin Frontal sinus stent
US5741333A (en) * 1995-04-12 1998-04-21 Corvita Corporation Self-expanding stent for a medical device to be introduced into a cavity of a body
US5824049A (en) * 1995-06-07 1998-10-20 Med Institute, Inc. Coated implantable medical device
US6652575B2 (en) * 1998-05-05 2003-11-25 Scimed Life Systems, Inc. Stent with smooth ends

Family Cites Families (665)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1080934A (en) 1912-08-19 1913-12-09 Walter L Shackleford Rectal tube.
US1200267A (en) 1915-02-04 1916-10-03 Motors Lock Company Of America Lock for automobile-hoods.
US1650959A (en) 1926-04-08 1927-11-29 Louis K Pitman Surgical instrument
US1735519A (en) 1926-07-17 1929-11-12 Arlyn T Vance Physician's dilator
US1878671A (en) 1929-07-02 1932-09-20 John Murray Dilator
US1828986A (en) 1929-09-26 1931-10-27 Golder E Stevens Dilating irrigator
US2525183A (en) 1947-03-20 1950-10-10 Jehu M Robison Antral pressure device
US3009265A (en) 1960-05-09 1961-11-21 Superior Plastics Inc Anatomical device
US3347061A (en) 1965-01-11 1967-10-17 Eaton Yale & Towne Flexible drive mechanism
US3486539A (en) 1965-09-28 1969-12-30 Jacuzzi Bros Inc Liquid dispensing and metering assembly
US3469578A (en) 1965-10-12 1969-09-30 Howard R Bierman Infusion device for ambulatory patients with flow control means
US3481043A (en) 1967-12-12 1969-12-02 Bendix Corp Gaging machine
US3531868A (en) 1968-04-18 1970-10-06 Ford Motor Co Surface scanner for measuring the coordinates of points on a three-dimensional surface
US3527220A (en) 1968-06-28 1970-09-08 Fairchild Hiller Corp Implantable drug administrator
US3993073A (en) 1969-04-01 1976-11-23 Alza Corporation Novel drug delivery device
US3624661A (en) 1969-05-14 1971-11-30 Honeywell Inc Electrographic printing system with plural staggered electrode rows
US3834394A (en) 1969-11-21 1974-09-10 R Sessions Occlusion device and method and apparatus for inserting the same
US3903893A (en) 1970-05-04 1975-09-09 Alexander L Scheer Nasal hemostatic device
US3850176A (en) 1972-02-07 1974-11-26 G Gottschalk Nasal tampon
US3910617A (en) 1972-02-20 1975-10-07 Square D Co Solenoid operated electric strike
JPS4932484U (en) 1972-06-19 1974-03-20
US3921636A (en) 1973-01-15 1975-11-25 Alza Corp Novel drug delivery device
US3993069A (en) 1973-03-26 1976-11-23 Alza Corporation Liquid delivery device bladder
US3993072A (en) 1974-08-28 1976-11-23 Alza Corporation Microporous drug delivery device
US4052505A (en) 1975-05-30 1977-10-04 Alza Corporation Ocular therapeutic system manufactured from copolymer
DE2541084C3 (en) 1975-09-15 1978-12-07 Siemens Ag, 1000 Berlin Und 8000 Muenchen Method for producing a self-supporting coil in the winding area
US4471779A (en) 1976-08-25 1984-09-18 Becton, Dickinson And Company Miniature balloon catheter
USRE31351E (en) 1978-08-04 1983-08-16 Bell Telephone Laboratories, Incorporated Feedback nonlinear equalization of modulated data signals
US4299226A (en) 1979-08-08 1981-11-10 Banka Vidya S Coronary dilation method
US4299227A (en) 1979-10-19 1981-11-10 Lincoff Harvey A Ophthalmological appliance
US4312353A (en) 1980-05-09 1982-01-26 Mayfield Education And Research Fund Method of creating and enlarging an opening in the brain
USD269204S (en) 1981-02-05 1983-05-31 Trepp Charles A Dental hygiene device
US5370675A (en) 1992-08-12 1994-12-06 Vidamed, Inc. Medical probe device and method
GB2125874B (en) 1982-08-17 1985-08-14 Michael David Dunn Solenoid operated locks
DE3376468D1 (en) 1983-06-27 1988-06-09 Borje Drettner An instrument for the treatment of sinusitis
USD283921S (en) 1983-06-27 1986-05-20 Difco Laboratories Incorporated Blood collector
US4554929A (en) 1983-07-13 1985-11-26 Advanced Cardiovascular Systems, Inc. Catheter guide wire with short spring tip and method of using the same
USD284892S (en) 1983-09-29 1986-07-29 Glassman Jacob A Biliary exploratory balloon catheter with replaceable lead-tip
JPS60253428A (en) 1984-05-30 1985-12-14 住友電気工業株式会社 Fiberscope with bending mechanism
US5019075A (en) 1984-10-24 1991-05-28 The Beth Israel Hospital Method and apparatus for angioplasty
US4691948A (en) 1985-11-27 1987-09-08 A-Dec, Inc. Fail-secure lock system
US5350395A (en) 1986-04-15 1994-09-27 Yock Paul G Angioplasty apparatus facilitating rapid exchanges
US4708834A (en) 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
CH668188A5 (en) * 1986-06-09 1988-12-15 Franz Rappai Corticosteroid ointment compsns. - comprise e.g. dexamethasone in poly:alkylene glycol base, and are used esp. for treating rhinitis
US5019372A (en) 1986-06-27 1991-05-28 The Children's Medical Center Corporation Magnetically modulated polymeric drug release system
US5030227A (en) 1988-06-02 1991-07-09 Advanced Surgical Intervention, Inc. Balloon dilation catheter
US4771776A (en) 1987-01-06 1988-09-20 Advanced Cardiovascular Systems, Inc. Dilatation catheter with angled balloon and method
US4793359A (en) 1987-04-24 1988-12-27 Gv Medical, Inc. Centering balloon structure for transluminal angioplasty catheter
US4867138A (en) 1987-05-13 1989-09-19 Olympus Optical Co., Ltd. Rigid electronic endoscope
DE3719250A1 (en) 1987-06-10 1988-12-22 Kellner Hans Joerg Dr Med ENDOSCOPE
SE8704767L (en) 1987-11-30 1989-05-31 Sigmund Johannes Loefstedt NEW METHOD FOR ADMINISTRATION OF MEDICINAL PRODUCTS
US5041089A (en) 1987-12-11 1991-08-20 Devices For Vascular Intervention, Inc. Vascular dilation catheter construction
US5372138A (en) 1988-03-21 1994-12-13 Boston Scientific Corporation Acousting imaging catheters and the like
US4883465A (en) 1988-05-24 1989-11-28 Brennan H George Nasal tampon and method for using
US4998917A (en) 1988-05-26 1991-03-12 Advanced Cardiovascular Systems, Inc. High torque steerable dilatation catheter
WO1989012477A1 (en) 1988-06-13 1989-12-28 Yaroslavsky Mezhotraslevoi Nauchno-Tekhnichesky Ts Device for diagnosing and treating nasal diseases
ES2032102T3 (en) 1988-06-29 1993-01-01 Jaico C.V. Cooperative Vennootschap PRESSURE CAPSULE FOR A SPRAY CONTAINER.
US5267965A (en) 1988-07-06 1993-12-07 Ethicon, Inc. Safety trocar
EP0355996A3 (en) 1988-07-21 1990-05-02 Advanced Interventional Systems, Inc. Guidance and delivery system for high-energy pulsed laser light and endoscope
US5067489A (en) 1988-08-16 1991-11-26 Flexmedics Corporation Flexible guide with safety tip
JPH0296072A (en) 1988-09-30 1990-04-06 Aisin Seiki Co Ltd Lid lock device
US4984581A (en) 1988-10-12 1991-01-15 Flexmedics Corporation Flexible guide having two-way shape memory alloy
JPH066342B2 (en) * 1988-10-14 1994-01-26 三菱重工業株式会社 Shape memory film and its use
US5090910A (en) 1988-10-14 1992-02-25 Narlo Jeanie R Multiple three dimensional facial display system
US4961433A (en) 1988-11-02 1990-10-09 Cardiometrics, Inc. Guide wire assembly with electrical functions and male and female connectors for use therewith
US5001825A (en) 1988-11-03 1991-03-26 Cordis Corporation Catheter guidewire fabrication method
US5189110A (en) * 1988-12-23 1993-02-23 Asahi Kasei Kogyo Kabushiki Kaisha Shape memory polymer resin, composition and the shape memorizing molded product thereof
US5087246A (en) 1988-12-29 1992-02-11 C. R. Bard, Inc. Dilation catheter with fluted balloon
US4998916A (en) 1989-01-09 1991-03-12 Hammerslag Julius G Steerable medical device
US5221260A (en) 1989-01-13 1993-06-22 Scimed Life Systems, Inc. Innerless dilatation balloon catheter
US5087244A (en) 1989-01-31 1992-02-11 C. R. Bard, Inc. Catheter and method for locally applying medication to the wall of a blood vessel or other body lumen
US5662674A (en) 1989-02-03 1997-09-02 Debbas; Elie Apparatus for locating a breast mass
US4966163A (en) 1989-02-14 1990-10-30 Advanced Cardiovascular Systems, Inc. Extendable guidewire for vascular procedures
US5024650A (en) 1989-02-15 1991-06-18 Matsushita Electric Works, Ltd. Stress dissolving refreshment system
SU1662571A1 (en) 1989-03-01 1991-07-15 Курский Государственный Медицинский Институт Process for preparing x-ray contrast agent for investigating sinuses
US4946466A (en) 1989-03-03 1990-08-07 Cordis Corporation Transluminal angioplasty apparatus
RU1768142C (en) 1989-03-29 1992-10-15 Ярославский Межотраслевой Научно-Технический Центр Device for therapy of sinuitis
DE69007841T2 (en) 1989-04-28 1994-08-11 Tokin Corp Rapidly operational guidewire for catheters using a memory alloy with pseudo-elasticity.
US5219334A (en) 1989-05-24 1993-06-15 Tsukada Medical Research Co., Ltd. Infuser with balloon for continuously infusing liquid drug
US4994033A (en) 1989-05-25 1991-02-19 Schneider (Usa) Inc. Intravascular drug delivery dilatation catheter
US5207695A (en) 1989-06-19 1993-05-04 Trout Iii Hugh H Aortic graft, implantation device, and method for repairing aortic aneurysm
US5308326A (en) 1989-06-28 1994-05-03 Zimmon David S Balloon tamponade devices and methods for their placement
DE3923851C1 (en) 1989-07-19 1990-08-16 Richard Wolf Gmbh, 7134 Knittlingen, De
DE3927001A1 (en) 1989-08-16 1991-02-21 Lucien C Dr Med Olivier CATHETER SYSTEM
US5180368A (en) 1989-09-08 1993-01-19 Advanced Cardiovascular Systems, Inc. Rapidly exchangeable and expandable cage catheter for repairing damaged blood vessels
US5169386A (en) 1989-09-11 1992-12-08 Bruce B. Becker Method and catheter for dilatation of the lacrimal system
US5021043A (en) 1989-09-11 1991-06-04 C. R. Bard, Inc. Method and catheter for dilatation of the lacrimal system
ATE91638T1 (en) 1989-09-25 1993-08-15 Schneider Usa Inc MULTI-LAYER EXTRUSION AS A PROCESS FOR MANUFACTURING BALLOONS FOR VESSEL PLASTIC.
US5256144A (en) 1989-11-02 1993-10-26 Danforth Biomedical, Inc. Low profile, high performance interventional catheters
US5026384A (en) 1989-11-07 1991-06-25 Interventional Technologies, Inc. Atherectomy systems and methods
US5112228A (en) 1989-11-13 1992-05-12 Advanced Cardiovascular Systems, Inc. Vascular model
US5215105A (en) 1989-11-14 1993-06-01 Custom Medical Concepts, Inc. Method of treating epidural lesions
US5137517A (en) 1989-11-28 1992-08-11 Scimed Life Systems, Inc. Device and method for gripping medical shaft
US5053007A (en) 1989-12-14 1991-10-01 Scimed Life Systems, Inc. Compression balloon protector for a balloon dilatation catheter and method of use thereof
US5439446A (en) 1994-06-30 1995-08-08 Boston Scientific Corporation Stent and therapeutic delivery system
US5843089A (en) 1990-12-28 1998-12-01 Boston Scientific Corporation Stent lining
US5209730A (en) 1989-12-19 1993-05-11 Scimed Life Systems, Inc. Method for placement of a balloon dilatation catheter across a stenosis and apparatus therefor
US5156595A (en) 1989-12-28 1992-10-20 Scimed Life Systems, Inc. Dilatation balloon catheter and method of manufacturing
USD329496S (en) 1990-02-20 1992-09-15 Celia Clarke Needle depth gauge
US5060660A (en) 1990-02-28 1991-10-29 C. R. Bard, Inc. Steerable extendable guidewire with adjustable tip
USD340111S (en) 1990-03-07 1993-10-05 Terumo Kabushiki Kaisha Catheter
US5478565A (en) 1990-03-27 1995-12-26 Warner-Lambert Company Treatment of sinus headache
US5171233A (en) 1990-04-25 1992-12-15 Microvena Corporation Snare-type probe
CA2082805A1 (en) 1990-05-11 1991-11-12 Mark A. Saab High-strength, thin-walled single piece catheters
SE502055C2 (en) 1990-05-23 1995-07-31 Atos Medical Ab Device for applying a drainage duct
WO1991019529A1 (en) 1990-06-15 1991-12-26 Cortrak Medical, Inc. Drug delivery apparatus and method
US5044678A (en) 1990-07-25 1991-09-03 Lectron Products, Inc. Solenoid operated latch device with movable pole piece
US5055051A (en) 1990-08-03 1991-10-08 Dornier Medical Systems, Inc. Semi-anthropomorphic biliary/renal training phantom for medical imaging and lithotripsy training
US5167220A (en) 1990-08-09 1992-12-01 Brown Cathy K Systems and methods for maintaining a clear visual field during endoscopic procedures
US5163989A (en) 1990-08-27 1992-11-17 Advanced Cardiovascular Systems, Inc. Method for forming a balloon mold and the use of such mold
US5345945A (en) 1990-08-29 1994-09-13 Baxter International Inc. Dual coil guidewire with radiopaque distal tip
US5197457A (en) 1990-09-12 1993-03-30 Adair Edwin Lloyd Deformable and removable sheath for optical catheter
DE4032096C2 (en) 1990-10-10 1995-03-30 Boehringer Ingelheim Kg Use of emulsifier-free emulsion polymers in pharmaceutical preparations with delayed release of the active ingredient
JP2699641B2 (en) 1990-10-11 1998-01-19 日本電気株式会社 Phase jitter suppression circuit
JPH0683726B2 (en) 1990-10-12 1994-10-26 日本精線株式会社 Guide wire for catheter
US5169043A (en) 1990-12-12 1992-12-08 Catania Claude L Versatile carrying bag
EP0824931A3 (en) 1990-12-18 1998-03-11 Advanced Cardiovascular Systems, Inc. Superelastic guiding member
US5341818A (en) 1992-12-22 1994-08-30 Advanced Cardiovascular Systems, Inc. Guidewire with superelastic distal portion
US5368558A (en) 1991-01-11 1994-11-29 Baxter International Inc. Ultrasonic ablation catheter device having endoscopic component and method of using same
US6006126A (en) 1991-01-28 1999-12-21 Cosman; Eric R. System and method for stereotactic registration of image scan data
US5465717A (en) 1991-02-15 1995-11-14 Cardiac Pathways Corporation Apparatus and Method for ventricular mapping and ablation
US5139510A (en) 1991-02-22 1992-08-18 Xomed-Treace Inc. Nasal packing device
US5183470A (en) 1991-03-04 1993-02-02 International Medical, Inc. Laparoscopic cholangiogram catheter and method of using same
US5195168A (en) 1991-03-15 1993-03-16 Codex Corporation Speech coder and method having spectral interpolation and fast codebook search
US6733473B1 (en) 1991-04-05 2004-05-11 Boston Scientific Corporation Adjustably stiffenable convertible catheter assembly
US5226302A (en) 1991-04-15 1993-07-13 Loctec Corporation Six-way self-adjusting lock for use on truck storage boxes and the like
CA2069052A1 (en) 1991-05-21 1992-11-22 L. Venkata Raman Superelastic formable guidewire
US5127393A (en) 1991-05-28 1992-07-07 Medilase, Inc. Flexible endoscope with rigid introducer
US5386817A (en) 1991-06-10 1995-02-07 Endomedical Technologies, Inc. Endoscope sheath and valve system
US5429582A (en) 1991-06-14 1995-07-04 Williams; Jeffery A. Tumor treatment
CA2068584C (en) 1991-06-18 1997-04-22 Paul H. Burmeister Intravascular guide wire and method for manufacture thereof
US5264260A (en) 1991-06-20 1993-11-23 Saab Mark A Dilatation balloon fabricated from low molecular weight polymers
US5236422A (en) 1991-06-24 1993-08-17 Eplett Jr James D Antiseptic urinary catheter cuff
US5766151A (en) 1991-07-16 1998-06-16 Heartport, Inc. Endovascular system for arresting the heart
US5252183A (en) 1991-09-13 1993-10-12 Abb Lummus Crest Inc. Process of pulping and bleaching fibrous plant material with tert-butyl alcohol and tert-butyl peroxide
US5168864A (en) 1991-09-26 1992-12-08 Clarus Medical Systems, Inc. Deflectable endoscope
US5304123A (en) 1991-10-24 1994-04-19 Children's Medical Center Corporation Detachable balloon catheter for endoscopic treatment of vesicoureteral reflux
US5290310A (en) 1991-10-30 1994-03-01 Howmedica, Inc. Hemostatic implant introducer
US5333620A (en) 1991-10-30 1994-08-02 C. R. Bard, Inc. High performance plastic coated medical guidewire
US5246016A (en) 1991-11-08 1993-09-21 Baxter International Inc. Transport catheter and multiple probe analysis method
US5251092A (en) 1991-11-27 1993-10-05 Protek Devices, Lp Receptacle assembly with both insulation displacement connector bussing and friction connector coupling of power conductors to surge suppressor circuit
US5243996A (en) 1992-01-03 1993-09-14 Cook, Incorporated Small-diameter superelastic wire guide
US6063079A (en) 1995-06-07 2000-05-16 Arthrocare Corporation Methods for electrosurgical treatment of turbinates
US6190381B1 (en) 1995-06-07 2001-02-20 Arthrocare Corporation Methods for tissue resection, ablation and aspiration
US6109268A (en) 1995-06-07 2000-08-29 Arthrocare Corporation Systems and methods for electrosurgical endoscopic sinus surgery
US6086585A (en) 1995-06-07 2000-07-11 Arthrocare Corporation System and methods for electrosurgical treatment of sleep obstructive disorders
US6053172A (en) 1995-06-07 2000-04-25 Arthrocare Corporation Systems and methods for electrosurgical sinus surgery
US5273052A (en) 1992-01-08 1993-12-28 Danforth Biomedical, Incorporated Guidewire with reversible contact seal for releasable securement to catheter
WO1993013827A1 (en) 1992-01-09 1993-07-22 Advanced Cardiovascular Systems, Inc. Guidewire replacement device
US5250059A (en) 1992-01-22 1993-10-05 Devices For Vascular Intervention, Inc. Atherectomy catheter having flexible nose cone
US5699796A (en) 1993-01-29 1997-12-23 Cardima, Inc. High resolution intravascular signal detection
US5341240A (en) 1992-02-06 1994-08-23 Linvatec Corporation Disposable endoscope
US5263926A (en) 1992-02-18 1993-11-23 Wilk Peter J Device and related method for reducing swelling of hemorrhoidal tissues
US5409444A (en) 1992-03-04 1995-04-25 Kensey Nash Corporation Method and apparatus to reduce injury to the vascular system
DE69326631T2 (en) 1992-03-19 2000-06-08 Medtronic Inc Intraluminal expansion device
US5346075A (en) 1992-04-17 1994-09-13 Johnson & Johnson Medical, Inc. Apparatus and method for holding a medical instrument
USD355031S (en) 1992-04-20 1995-01-31 Terumo Kabushiki Kaisha Catheter
US5368566A (en) 1992-04-29 1994-11-29 Cardiovascular Dynamics, Inc. Delivery and temporary stent catheter having a reinforced perfusion lumen
US5275593A (en) 1992-04-30 1994-01-04 Surgical Technologies, Inc. Ophthalmic surgery probe assembly
US5817102A (en) 1992-05-08 1998-10-06 Schneider (Usa) Inc. Apparatus for delivering and deploying a stent
US5584827A (en) 1992-05-18 1996-12-17 Ultracell Medical Technologies, Inc Nasal-packing article
US5713848A (en) 1993-05-19 1998-02-03 Dubrul; Will R. Vibrating catheter
US5255679A (en) 1992-06-02 1993-10-26 Cardiac Pathways Corporation Endocardial catheter for mapping and/or ablation with an expandable basket structure having means for providing selective reinforcement and pressure sensing mechanism for use therewith, and method
US5324284A (en) 1992-06-05 1994-06-28 Cardiac Pathways, Inc. Endocardial mapping and ablation system utilizing a separately controlled ablation catheter and method
US5348537A (en) 1992-07-15 1994-09-20 Advanced Cardiovascular Systems, Inc. Catheter with intraluminal sealing element
US5313967A (en) 1992-07-24 1994-05-24 Medtronic, Inc. Helical guidewire
US5514131A (en) 1992-08-12 1996-05-07 Stuart D. Edwards Method for the ablation treatment of the uvula
DE69325692T2 (en) 1992-08-18 2000-01-05 Spectranetics Corp Guide wire with fiber optics
IT1258142B (en) 1992-09-04 1996-02-20 NASAL AND / OR RHINOPARINGEOUS SWAB
US5647361A (en) 1992-09-28 1997-07-15 Fonar Corporation Magnetic resonance imaging method and apparatus for guiding invasive therapy
WO1994008647A1 (en) 1992-10-15 1994-04-28 The General Hospital Corporation An infusion pump with an electronically loadable drug library
US5356418A (en) 1992-10-28 1994-10-18 Shturman Cardiology Systems, Inc. Apparatus and method for rotational atherectomy
US5295694A (en) 1992-10-27 1994-03-22 Levin John M Laparoscopic surgery simulating game
US5336178A (en) 1992-11-02 1994-08-09 Localmed, Inc. Intravascular catheter with infusion array
US5549542A (en) 1992-11-17 1996-08-27 Life Medical Technologies, Inc. Deflectable endoscope
EP0669820B1 (en) 1992-11-18 1997-04-16 Spectrascience, Inc. Apparatus for diagnostic imaging
US5391147A (en) 1992-12-01 1995-02-21 Cardiac Pathways Corporation Steerable catheter with adjustable bend location and/or radius and method
US5314417A (en) 1992-12-22 1994-05-24 Ethicon, Inc. Safety trocar
US5368564A (en) 1992-12-23 1994-11-29 Angeion Corporation Steerable catheter
US5336163A (en) * 1993-01-06 1994-08-09 Smith & Nephew Richards, Inc. Expandable nasal stent
CN2151720Y (en) 1993-01-08 1994-01-05 陈吉峰 Hemostat for nasal cavity and nasopharynx cavity
WO1994015533A2 (en) 1993-01-18 1994-07-21 John Crowe Endoscope forceps
JP3345147B2 (en) 1993-01-26 2002-11-18 テルモ株式会社 Vasodilators and catheters
US5407433A (en) 1993-02-10 1995-04-18 Origin Medsystems, Inc. Gas-tight seal accommodating surgical instruments with a wide range of diameters
US5329927A (en) 1993-02-25 1994-07-19 Echo Cath, Inc. Apparatus and method for locating an interventional medical device with a ultrasound color imaging system
JP3553067B2 (en) 1993-04-13 2004-08-11 ボストン・サイエンティフィック・リミテッド Prosthesis introduction device with extended tip
US5985307A (en) 1993-04-14 1999-11-16 Emory University Device and method for non-occlusive localized drug delivery
US5350396A (en) 1993-04-15 1994-09-27 Hood Laboratories Nasal splint
US5464650A (en) 1993-04-26 1995-11-07 Medtronic, Inc. Intravascular stent and method
US5824048A (en) 1993-04-26 1998-10-20 Medtronic, Inc. Method for delivering a therapeutic substance to a body lumen
EP0623582B1 (en) 1993-04-27 1998-01-07 Solvay Fluor und Derivate GmbH Process for the preparation of esters of carboxylic acids from carboxylic acid halogenides and alcohols
US5346508A (en) 1993-04-29 1994-09-13 Scimed Life Systems, Inc. Apparatus and method for performing diagnostics and intravascular therapies
US5617870A (en) 1993-04-29 1997-04-08 Scimed Life Systems, Inc. Intravascular flow measurement system
US5873835A (en) 1993-04-29 1999-02-23 Scimed Life Systems, Inc. Intravascular pressure and flow sensor
US5450853A (en) 1993-10-22 1995-09-19 Scimed Life Systems, Inc. Pressure sensor
US6832996B2 (en) 1995-06-07 2004-12-21 Arthrocare Corporation Electrosurgical systems and methods for treating tissue
DE4315821A1 (en) 1993-05-12 1994-11-17 Christian Dr Med Milewski Device for tamponade and for keeping open bone-restricted body cavities and passages after surgical manipulation
US5372584A (en) 1993-06-24 1994-12-13 Ovamed Corporation Hysterosalpingography and selective salpingography
JP3337272B2 (en) 1993-06-29 2002-10-21 株式会社町田製作所 Medical equipment
US5402799A (en) 1993-06-29 1995-04-04 Cordis Corporation Guidewire having flexible floppy tip
US5964745A (en) 1993-07-02 1999-10-12 Med Usa Implantable system for cell growth control
US5391199A (en) 1993-07-20 1995-02-21 Biosense, Inc. Apparatus and method for treating cardiac arrhythmias
US5472449A (en) 1993-07-26 1995-12-05 Chou; Kuei C. Permanent pigment applicator having a detachable needle coupler
US5415633A (en) 1993-07-28 1995-05-16 Active Control Experts, Inc. Remotely steered catheterization device
US5441494A (en) 1993-07-29 1995-08-15 Ethicon, Inc. Manipulable hand for laparoscopy
US6277107B1 (en) 1993-08-13 2001-08-21 Daig Corporation Guiding introducer for introducing medical devices into the coronary sinus and process for using same
US5562619A (en) 1993-08-19 1996-10-08 Boston Scientific Corporation Deflectable catheter
US5578048A (en) 1993-09-15 1996-11-26 United States Surgical Corporation Manipulator apparatus
JPH09503404A (en) 1993-09-20 1997-04-08 ボストン・サイエンティフィック・コーポレーション Multiple biopsy sample collection device
US5607386A (en) 1993-09-21 1997-03-04 Flam; Gary H. Malleable fiberoptic intubating stylet and method
US5558091A (en) 1993-10-06 1996-09-24 Biosense, Inc. Magnetic determination of position and orientation
US5400783A (en) 1993-10-12 1995-03-28 Cardiac Pathways Corporation Endocardial mapping apparatus with rotatable arm and method
US5465733A (en) 1993-10-14 1995-11-14 Hinohara; Tomoaki Guide wire for catheters and method for its use
US5437282A (en) 1993-10-29 1995-08-01 Boston Scientific Corporation Drive shaft for acoustic imaging catheters and flexible catheters
US5720300A (en) 1993-11-10 1998-02-24 C. R. Bard, Inc. High performance wires for use in medical devices and alloys therefor
US5507301A (en) 1993-11-19 1996-04-16 Advanced Cardiovascular Systems, Inc. Catheter and guidewire system with flexible distal portions
US5334167A (en) 1993-11-19 1994-08-02 Cocanower David A Modified nasogastric tube for use in enteral feeding
US6673025B1 (en) 1993-12-01 2004-01-06 Advanced Cardiovascular Systems, Inc. Polymer coated guidewire
US5451221A (en) 1993-12-27 1995-09-19 Cynosure, Inc. Endoscopic light delivery system
US6716216B1 (en) 1998-08-14 2004-04-06 Kyphon Inc. Systems and methods for treating vertebral bodies
US5538510A (en) 1994-01-31 1996-07-23 Cordis Corporation Catheter having coextruded tubing
SE9400364D0 (en) 1994-02-02 1994-02-02 Sven Eric Stangerup Nasal catheter and procedure for the treatment of nasal bleeding
US5904701A (en) 1994-02-14 1999-05-18 Daneshvar; Yousef Device for aiding procedural and therapeutic interventions of the gastrointestinal tract
US5591194A (en) 1994-02-18 1997-01-07 C. R. Bard, Inc. Telescoping balloon catheter and method of use
US5411016A (en) 1994-02-22 1995-05-02 Scimed Life Systems, Inc. Intravascular balloon catheter for use in combination with an angioscope
AUPM409094A0 (en) 1994-02-25 1994-03-24 Trimec Securities Pty. Limited Improvements in electromagnetic locks
US5582167A (en) 1994-03-02 1996-12-10 Thomas Jefferson University Methods and apparatus for reducing tracheal infection using subglottic irrigation, drainage and servoregulation of endotracheal tube cuff pressure
US5425370A (en) 1994-03-23 1995-06-20 Echocath, Inc. Method and apparatus for locating vibrating devices
US5887467A (en) 1994-03-30 1999-03-30 U-Code, Inc. Pawl & solenoid locking mechanism
US5454817A (en) 1994-04-11 1995-10-03 Katz; David L. Oto-nasal foreign body extractor
US5533985A (en) 1994-04-20 1996-07-09 Wang; James C. Tubing
US5599304A (en) 1994-05-10 1997-02-04 Mount Sinai School Of Medicine Of The City University Of New York Sinonasal suction apparatus
US6139510A (en) 1994-05-11 2000-10-31 Target Therapeutics Inc. Super elastic alloy guidewire
US5824044A (en) 1994-05-12 1998-10-20 Endovascular Technologies, Inc. Bifurcated multicapsule intraluminal grafting system
US5551946A (en) 1994-05-17 1996-09-03 Bullard; James R. Multifunctional intubating guide stylet and laryngoscope
US5497783A (en) 1994-05-18 1996-03-12 Scimed Life Systems, Inc. Guidewire having radioscopic tip
US5569183A (en) 1994-06-01 1996-10-29 Archimedes Surgical, Inc. Method for performing surgery around a viewing space in the interior of the body
WO1995035132A1 (en) 1994-06-17 1995-12-28 Hisamitsu Pharmaceutical Co., Inc. Electrode for iontophoresis and device using the same
US5633000A (en) 1994-06-23 1997-05-27 Axxia Technologies Subcutaneous implant
US5857998A (en) 1994-06-30 1999-01-12 Boston Scientific Corporation Stent and therapeutic delivery system
US5458572A (en) 1994-07-01 1995-10-17 Boston Scientific Corp. Catheter with balloon folding into predetermined configurations and method of manufacture
US5441497A (en) 1994-07-14 1995-08-15 Pdt Cardiovascular, Inc. Light diffusing guidewire
US5486181A (en) 1994-08-04 1996-01-23 Implex Corporation Acetabular cup, method and tool and installing the same
US6579285B2 (en) 1994-09-09 2003-06-17 Cardiofocus, Inc. Photoablation with infrared radiation
DE69531994T2 (en) 1994-09-15 2004-07-22 OEC Medical Systems, Inc., Boston SYSTEM FOR POSITION DETECTION BY MEANS OF A REFERENCE UNIT ATTACHED TO A PATIENT'S HEAD FOR USE IN THE MEDICAL AREA
US5673707A (en) 1994-09-23 1997-10-07 Boston Scientific Corporation Enhanced performance guidewire
US5558652A (en) 1994-10-06 1996-09-24 B. Braun Medical, Inc. Introducer with radiopaque marked tip and method of manufacture therefor
US5722401A (en) 1994-10-19 1998-03-03 Cardiac Pathways Corporation Endocardial mapping and/or ablation catheter probe
US6458070B1 (en) 1994-10-27 2002-10-01 Novoste Corporation Method and apparatus for treating a desired area in the vascular system of a patient
US5814029A (en) 1994-11-03 1998-09-29 Daig Corporation Guiding introducer system for use in ablation and mapping procedures in the left ventricle
AU708529B2 (en) 1994-11-10 1999-08-05 University Of Kentucky Research Foundation, The Implantable refillable controlled release device to deliver drugs directly to an internal portion of the body
US6059752A (en) 1994-12-09 2000-05-09 Segal; Jerome Mechanical apparatus and method for dilating and irradiating a site of treatment
US5637113A (en) 1994-12-13 1997-06-10 Advanced Cardiovascular Systems, Inc. Polymer film for wrapping a stent structure
US5664580A (en) 1995-01-31 1997-09-09 Microvena Corporation Guidewire having bimetallic coil
US5599576A (en) 1995-02-06 1997-02-04 Surface Solutions Laboratories, Inc. Medical apparatus with scratch-resistant coating and method of making same
US5599284A (en) 1995-02-08 1997-02-04 Shea; John P. Pre-operative nasal splint for endoscopic sinus surgery and method
US6830785B1 (en) 1995-03-20 2004-12-14 Toto Ltd. Method for photocatalytically rendering a surface of a substrate superhydrophilic, a substrate with a superhydrophilic photocatalytic surface, and method of making thereof
WO1996029071A1 (en) * 1995-03-21 1996-09-26 Ramot University Authority For Applied Research & Industrial Development Ltd. Uses of antibacterial compounds
DE69625831T2 (en) 1995-03-23 2003-11-20 Advanced Animal Technology Ltd Device for administering a substance
EP0819014B1 (en) 1995-03-30 2003-02-05 Heartport, Inc. Endovascular cardiac venting catheter
KR960032597U (en) 1995-03-31 1996-10-24 Tape recorder reservation recording switch
US5685838A (en) 1995-04-17 1997-11-11 Xomed-Treace, Inc. Sinus debrider apparatus
US5837313A (en) 1995-04-19 1998-11-17 Schneider (Usa) Inc Drug release stent coating process
US6638291B1 (en) 1995-04-20 2003-10-28 Micrus Corporation Three dimensional, low friction vasoocclusive coil, and method of manufacture
US5752522A (en) 1995-05-04 1998-05-19 Cardiovascular Concepts, Inc. Lesion diameter measurement catheter and method
US6122541A (en) 1995-05-04 2000-09-19 Radionics, Inc. Head band for frameless stereotactic registration
US5735817A (en) 1995-05-19 1998-04-07 Shantha; T. R. Apparatus for transsphenoidal stimulation of the pituitary gland and adjoining brain structures
US5656030A (en) 1995-05-22 1997-08-12 Boston Scientific Corporation Bidirectional steerable catheter with deflectable distal tip
DE69638035D1 (en) 1995-05-26 2009-11-05 Ishihara Sangyo Kaisha Process for the preparation of substituted 1,1,1-trifluoro-3-buten-2-ones
US5833650A (en) 1995-06-05 1998-11-10 Percusurge, Inc. Catheter apparatus and method for treating occluded vessels
US5707389A (en) 1995-06-07 1998-01-13 Baxter International Inc. Side branch occlusion catheter device having integrated endoscope for performing endoscopically visualized occlusion of the side branches of an anatomical passageway
US5752513A (en) 1995-06-07 1998-05-19 Biosense, Inc. Method and apparatus for determining position of object
US6238391B1 (en) 1995-06-07 2001-05-29 Arthrocare Corporation Systems for tissue resection, ablation and aspiration
WO1996040342A1 (en) 1995-06-07 1996-12-19 Cardima, Inc. Guiding catheter for coronary sinus
US5729129A (en) 1995-06-07 1998-03-17 Biosense, Inc. Magnetic location system with feedback adjustment of magnetic field generator
US5697400A (en) 1995-06-29 1997-12-16 Trw Fahrwerksysteme Gmbh & Co. Kg Steering valve
US5645789A (en) 1995-07-20 1997-07-08 Navius Corporation Distensible pet balloon and method of manufacture
US5638819A (en) 1995-08-29 1997-06-17 Manwaring; Kim H. Method and apparatus for guiding an instrument to a target
US5669388A (en) 1995-09-06 1997-09-23 Echocath, Inc. Apparatus and method for automatic placement of transducer
US5601594A (en) * 1995-09-14 1997-02-11 Best; Barry D. Nasal stent
GB2305174A (en) 1995-09-15 1997-04-02 Zeneca Ltd Chemical process
US6027461A (en) 1995-10-11 2000-02-22 Micro Therapeutics, Inc. Infusion guidewire having fixed core wire and flexible radiopaque marker
US6283951B1 (en) 1996-10-11 2001-09-04 Transvascular, Inc. Systems and methods for delivering drugs to selected locations within the body
AU726713B2 (en) 1995-10-13 2000-11-16 Transvascular, Inc. Methods and apparatus for bypassing arterial obstructions and/or performing other transvascular procedures
US6302875B1 (en) 1996-10-11 2001-10-16 Transvascular, Inc. Catheters and related devices for forming passageways between blood vessels or other anatomical structures
US6375615B1 (en) 1995-10-13 2002-04-23 Transvascular, Inc. Tissue penetrating catheters having integral imaging transducers and their methods of use
US5916149A (en) 1995-10-25 1999-06-29 Ryan, Jr.; Edwin H. Shielded illumination device for ophthalmic surgery and the like
US6113567A (en) 1995-10-25 2000-09-05 Becker; Bruce B. Lacrimal silicone tube with reduced friction
US6019736A (en) 1995-11-06 2000-02-01 Francisco J. Avellanet Guidewire for catheter
US5843050A (en) 1995-11-13 1998-12-01 Micro Therapeutics, Inc. Microcatheter
US5827224A (en) 1995-11-22 1998-10-27 Shippert; Ronald D. Pressure applying fluid transfer medical device
FI100318B (en) 1995-11-23 1997-11-14 Fiskars Consumer Oy Ab Articulated hand tools
US5733248A (en) 1995-11-29 1998-03-31 Scimed Life Systems, Inc. Universal guide catheter
DE69728257T2 (en) 1996-01-08 2005-03-10 Biosense Inc. DEVICE FOR MYOCARDIAL VASCULATION
US5722984A (en) 1996-01-16 1998-03-03 Iso Stent, Inc. Antithrombogenic radioactive coating for an intravascular stent
US6039699A (en) 1996-01-22 2000-03-21 Cordis Corporation Stiff catheter guidewire with flexible distal portion
US5711315A (en) 1996-02-15 1998-01-27 Jerusalmy; Israel Sinus lift method
US6332089B1 (en) 1996-02-15 2001-12-18 Biosense, Inc. Medical procedures and apparatus using intrabody probes
US6860264B2 (en) 1996-02-26 2005-03-01 Evergreen Medical Incorporated Method and apparatus for endotracheal intubation using a light wand and curved guide
US5817013A (en) 1996-03-19 1998-10-06 Enable Medical Corporation Method and apparatus for the minimally invasive harvesting of a saphenous vein and the like
US5682199A (en) 1996-03-28 1997-10-28 Jedmed Instrument Company Video endoscope with interchangeable endoscope heads
US5779699A (en) 1996-03-29 1998-07-14 Medtronic, Inc. Slip resistant field focusing ablation catheter electrode
US5980503A (en) 1996-04-08 1999-11-09 Guidant Corporation Endoscopic cardioplegia infusion cannula and method of use
DE59701917C5 (en) 1996-04-10 2013-06-06 Curaden Ag APPARATUS FOR DETERMINING THE APPROXIMAL DURABILITY OF A DENTAL INTERIOR
US6549800B1 (en) 1996-04-25 2003-04-15 Johns Hopkins Unversity School Of Medicine Methods for in vivo magnetic resonance imaging
US6171298B1 (en) 1996-05-03 2001-01-09 Situs Corporation Intravesical infuser
US7022105B1 (en) 1996-05-06 2006-04-04 Novasys Medical Inc. Treatment of tissue in sphincters, sinuses and orifices
US6503087B1 (en) 1996-05-08 2003-01-07 Gaumard Scientific, Inc. Interactive education system for teaching patient care
US6270477B1 (en) 1996-05-20 2001-08-07 Percusurge, Inc. Catheter for emboli containment
US6652480B1 (en) 1997-03-06 2003-11-25 Medtronic Ave., Inc. Methods for reducing distal embolization
US6167296A (en) 1996-06-28 2000-12-26 The Board Of Trustees Of The Leland Stanford Junior University Method for volumetric image navigation
US5789391A (en) 1996-07-03 1998-08-04 Inspire Pharmaceuticals, Inc. Method of treating sinusitis with uridine triphosphates and related compounds
US5865767A (en) 1996-07-10 1999-02-02 Cordis Corporation Guidewire having compound taper
US5664567A (en) 1996-07-16 1997-09-09 Linder; Gerald S. Fenestrated nasopharyngeal airway for drainage
US6569147B1 (en) 1996-07-26 2003-05-27 Kensey Nash Corporation Systems and methods of use for delivering beneficial agents for revascularizing stenotic bypass grafts and other occluded blood vessels and for other purposes
US6126682A (en) 1996-08-13 2000-10-03 Oratec Interventions, Inc. Method for treating annular fissures in intervertebral discs
US5797878A (en) 1996-08-15 1998-08-25 Guidant Corporation Catheter having optimized balloon taper angle
US5833682A (en) 1996-08-26 1998-11-10 Illumenex Corporation Light delivery system with blood flushing capability
US5843113A (en) 1996-10-08 1998-12-01 High; Kenneth Endocystotomy tool
US5971975A (en) 1996-10-09 1999-10-26 Target Therapeutics, Inc. Guide catheter with enhanced guidewire tracking
US5820568A (en) 1996-10-15 1998-10-13 Cardiac Pathways Corporation Apparatus and method for aiding in the positioning of a catheter
US6016439A (en) 1996-10-15 2000-01-18 Biosense, Inc. Method and apparatus for synthetic viewpoint imaging
US5779669A (en) 1996-10-28 1998-07-14 C. R. Bard, Inc. Steerable catheter with fixed curve
US6913763B2 (en) 1996-11-19 2005-07-05 Intrabrain International Nv Method and device for enhanced delivery of a biologically active agent through the spinal spaces into the central nervous system of a mammal
US5872879A (en) 1996-11-25 1999-02-16 Boston Scientific Corporation Rotatable connecting optical fibers
US5836638A (en) 1996-12-09 1998-11-17 Illinois Tool Works Inc. Fuel door assembly
US5830188A (en) 1996-12-11 1998-11-03 Board Of Regents, The University Of Texas System Curved cannula for continuous spinal anesthesia
US5766194A (en) 1996-12-23 1998-06-16 Georgia Skin And Cancer Clinic, Pc Surgical apparatus for tissue removal
US5935061A (en) 1997-01-03 1999-08-10 Biosense, Inc. Obstetrical instrument system and method
US6007516A (en) 1997-01-21 1999-12-28 Vasca, Inc. Valve port and method for vascular access
US5980551A (en) * 1997-02-07 1999-11-09 Endovasc Ltd., Inc. Composition and method for making a biodegradable drug delivery stent
US6669689B2 (en) 1997-02-27 2003-12-30 Cryocath Technologies Inc. Cryosurgical catheter
US6190332B1 (en) 1998-02-19 2001-02-20 Percusurge, Inc. Core wire with shapeable tip
US6159170A (en) 1997-03-13 2000-12-12 Borodulin; German Universal mechanical dilator combined with massaging action
US6007991A (en) * 1997-03-28 1999-12-28 The Research Foundation Of Suny Antisense oligonucleotides for mitogen-activated protein kinases as therapy for cancer
US6524299B1 (en) 1997-04-09 2003-02-25 Target Therapeutics, Inc. Flow-directed catheter
US5941816A (en) 1997-04-15 1999-08-24 Clarus Medical Systems, Inc. Viewing system with adapter handle for medical breathing tubes
US6019777A (en) 1997-04-21 2000-02-01 Advanced Cardiovascular Systems, Inc. Catheter and method for a stent delivery system
US5862693A (en) 1997-05-02 1999-01-26 Fort Lock Corporation Electronically controlled security lock
US6016429A (en) 1997-05-28 2000-01-18 Northern Telecom Limited Method and apparatus for minimizing cellular network costs when upgrading the electronics in an existing cellular system
EP0988081A1 (en) 1997-06-04 2000-03-29 Advanced Cardiovascular Systems, Inc. Steerable guidewire with enhanced distal support
US5997562A (en) 1997-06-13 1999-12-07 Percusurge, Inc. Medical wire introducer and balloon protective sheath
DE19728273C1 (en) 1997-07-02 1998-12-10 Fuss Fritz Gmbh & Co Locking device for furniture
US6514249B1 (en) 1997-07-08 2003-02-04 Atrionix, Inc. Positioning system and method for orienting an ablation element within a pulmonary vein ostium
US20010004644A1 (en) 1997-07-21 2001-06-21 Levin Bruce H. Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation
US6432986B2 (en) 1997-07-21 2002-08-13 Bruce H. Levin Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
US5928192A (en) 1997-07-24 1999-07-27 Embol-X, Inc. Arterial aspiration
US5908407A (en) 1997-07-25 1999-06-01 Neuroperfusion, Inc. Retroperfusion catheter apparatus and method
DE19732031C1 (en) 1997-07-25 1999-04-22 Solvay Fluor & Derivate 2-phase production of carboxylic acid esters
US6015414A (en) 1997-08-29 2000-01-18 Stereotaxis, Inc. Method and apparatus for magnetically controlling motion direction of a mechanically pushed catheter
US5902247A (en) 1997-09-09 1999-05-11 Bioenterics Corporation Transilluminating catheter
US6066149A (en) 1997-09-30 2000-05-23 Target Therapeutics, Inc. Mechanical clot treatment device with distal filter
JP2001518328A (en) 1997-10-01 2001-10-16 ボストン サイエンティフィック リミテッド Expansion system and related methods
US6027478A (en) 1997-10-09 2000-02-22 Medical Purchasing Group, Inc. Nasal cavity drainage and stoppage system
US6042561A (en) 1997-10-22 2000-03-28 Ash Medical Systems, Inc. Non-intravascular infusion access device
US6056702A (en) 1998-10-02 2000-05-02 Cordis Corporation Guidewire with outer sheath
FR2770409B1 (en) 1997-10-31 2000-06-23 Soprane Sa UNIVERSAL CATHETER
JP4121615B2 (en) 1997-10-31 2008-07-23 オリンパス株式会社 Endoscope
US6048299A (en) 1997-11-07 2000-04-11 Radiance Medical Systems, Inc. Radiation delivery catheter
US6179811B1 (en) 1997-11-25 2001-01-30 Medtronic, Inc. Imbedded marker and flexible guide wire shaft
AU1712599A (en) 1997-12-08 1999-06-28 Cardeon Corporation Aortic catheter and methods for inducing cardioplegic arrest and for selective aortic perfusion
US6093150A (en) 1997-12-31 2000-07-25 Acuson Corporation Ultrasound otoscope
US7008412B2 (en) 1998-01-06 2006-03-07 Cathlogic, Inc. Subcutaneous port catheter system and associated method
US5989231A (en) 1998-01-15 1999-11-23 Scimed Life Systems, Inc. Optical gastrostomy and jejunostomy
US6159178A (en) 1998-01-23 2000-12-12 Heartport, Inc. Methods and devices for occluding the ascending aorta and maintaining circulation of oxygenated blood in the patient when the patient's heart is arrested
US6083188A (en) 1998-02-04 2000-07-04 Becker; Bruce B. Lacrimal silicone stent with very large diameter segment insertable transnasally
US7371210B2 (en) 1998-02-24 2008-05-13 Hansen Medical, Inc. Flexible instrument
US6176829B1 (en) 1998-02-26 2001-01-23 Echocath, Inc. Multi-beam diffraction grating imager apparatus and method
US6183461B1 (en) 1998-03-11 2001-02-06 Situs Corporation Method for delivering a medication
JPH11265567A (en) 1998-03-17 1999-09-28 Mitsumi Electric Co Ltd Disk drive
DE19813383A1 (en) 1998-03-26 1999-10-07 Storz Karl Gmbh & Co Device with a transmitter unit, via which the position of a medical instrument can be detected in the context of a CAS system
ATE308276T1 (en) 1998-03-31 2005-11-15 Transvascular Inc TISSUE-PENETRATING CATHETER WITH TRANSDUCER FOR IMAGING AND ASSOCIATED METHODS OF APPLICATION
US6013019A (en) 1998-04-06 2000-01-11 Isostent, Inc. Temporary radioisotope stent
US5968085A (en) 1998-04-20 1999-10-19 Medtronic, Inc. Pacing lead with integral guidance using ultrasound
JP2002513037A (en) 1998-04-24 2002-05-08 ジェネンテック・インコーポレーテッド FIZZ protein
US6450989B2 (en) 1998-04-27 2002-09-17 Artemis Medical, Inc. Dilating and support apparatus with disease inhibitors and methods for use
US6175752B1 (en) 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US6306105B1 (en) 1998-05-14 2001-10-23 Scimed Life Systems, Inc. High performance coil wire
US6183464B1 (en) 1998-06-01 2001-02-06 Inviro Medical Devices Ltd. Safety syringe with retractable needle and universal luer coupling
US6048358A (en) 1998-07-13 2000-04-11 Barak; Shlomo Method and apparatus for hemostasis following arterial catheterization
US6352503B1 (en) 1998-07-17 2002-03-05 Olympus Optical Co., Ltd. Endoscopic surgery apparatus
US5979290A (en) 1998-07-20 1999-11-09 Simeone; Salvatore Mine clearing device
NL1009738C2 (en) 1998-07-24 2000-01-25 Cordis Europ Balloon catheter with filler for stent delivery.
US20040064105A1 (en) 2002-09-27 2004-04-01 Capes David Francis Single-use syringe
US6168586B1 (en) 1998-08-07 2001-01-02 Embol-X, Inc. Inflatable cannula and method of using same
US5954694A (en) 1998-08-07 1999-09-21 Embol-X, Inc. Nested tubing sections and methods for making same
US6129713A (en) 1998-08-11 2000-10-10 Embol-X, Inc. Slidable cannula and method of use
CN2352818Y (en) 1998-08-12 1999-12-08 李平 Medical use light guide
JP3244660B2 (en) 1998-08-17 2002-01-07 旭光学工業株式会社 Endoscope treatment tool
AU5196999A (en) 1998-08-17 2000-03-06 Kazuhiro Noda Operation balloon
USD413629S (en) 1998-08-18 1999-09-07 HA-LO Industries, Inc. Nasal tract model
ES2216556T3 (en) 1998-08-19 2004-10-16 Cook Incorporated PREFORMED WIRE GUIDE.
US6149213A (en) 1998-10-01 2000-11-21 Southco, Inc. Blind latch keeper
DE69939655D1 (en) 1998-10-05 2008-11-13 Kaneka Corp Balloon catheter
WO2000027461A1 (en) 1998-11-09 2000-05-18 Datascope Investment Corp. Intra-aortic balloon catheter having an ultra-thin stretch blow molded balloon membrane
US6174280B1 (en) 1998-11-19 2001-01-16 Vision Sciences, Inc. Sheath for protecting and altering the bending characteristics of a flexible endoscope
US6234958B1 (en) 1998-11-30 2001-05-22 Medical Access Systems, Llc Medical device introduction system including medical introducer having a plurality of access ports and methods of performing medical procedures with same
US20030018291A1 (en) 1999-12-08 2003-01-23 Hill Frank C. Ear tube and method of insertion
US6464650B2 (en) 1998-12-31 2002-10-15 Advanced Cardiovascular Systems, Inc. Guidewire with smoothly tapered segment
US6206870B1 (en) 1999-01-21 2001-03-27 Quest Medical, Inc. Catheter stylet handle
WO2000044432A1 (en) 1999-01-27 2000-08-03 Levin Bruce H Compositions, kits, apparatus, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
DE19906191A1 (en) 1999-02-15 2000-08-17 Ingo F Herrmann Mouldable endoscope for transmitting light and images with supplementary device has non-round cross section along longitudinal section for inserting in human or animal body opening
US6332891B1 (en) 1999-02-16 2001-12-25 Stryker Corporation System and method for performing image guided surgery
US6398758B1 (en) 1999-02-16 2002-06-04 Stephen C. Jacobsen Medicament delivery system
US6468297B1 (en) 1999-02-24 2002-10-22 Cryovascular Systems, Inc. Cryogenically enhanced intravascular interventions
WO2000053252A1 (en) * 1999-03-08 2000-09-14 University Of Virginia Patent Foundation Device and method for delivering a material into the paranasal sinus cavities
US6148823A (en) 1999-03-17 2000-11-21 Stereotaxis, Inc. Method of and system for controlling magnetic elements in the body using a gapped toroid magnet
US6200257B1 (en) 1999-03-24 2001-03-13 Proxima Therapeutics, Inc. Catheter with permeable hydrogel membrane
US6389313B1 (en) 1999-03-26 2002-05-14 Kevin S. Marchitto Laser probes for drug permeation
US6258065B1 (en) 1999-03-26 2001-07-10 Core Dynamics, Inc. Surgical instrument seal assembly
ATE266442T1 (en) 1999-03-29 2004-05-15 Cook William Europ A GUIDE WIRE
EP1040843B1 (en) 1999-03-29 2005-09-28 William Cook Europe A/S A guidewire
US6425877B1 (en) 1999-04-02 2002-07-30 Novasys Medical, Inc. Treatment of tissue in the digestive circulatory respiratory urinary and reproductive systems
US6328564B1 (en) 1999-04-06 2001-12-11 Raymond C. Thurow Deep ear canal locating and head orienting device
US6319275B1 (en) 1999-04-07 2001-11-20 Medtronic Ave, Inc. Endolumenal prosthesis delivery assembly and method of use
US6231543B1 (en) 1999-04-15 2001-05-15 Intella Interventional Systems, Inc. Single lumen balloon catheter
DE59900101D1 (en) 1999-04-29 2001-06-28 Storz Karl Gmbh & Co Kg Medical instrument for tissue preparation
US6268574B1 (en) 1999-04-29 2001-07-31 Rudolph R. Edens Electrical and pneumatic lock-out device
US6689146B1 (en) 1999-04-29 2004-02-10 Stryker Corporation Powered surgical handpiece with integrated irrigator and suction application
WO2000065987A1 (en) 1999-04-30 2000-11-09 Applied Medical Resources Corporation Guidewire
EP1176923A1 (en) 1999-05-07 2002-02-06 Salviac Limited An embolic protection device
US6758830B1 (en) 1999-05-11 2004-07-06 Atrionix, Inc. Catheter positioning system
US6394093B1 (en) 1999-05-13 2002-05-28 Scott Lethi Nasopharyngeal airway with inflatable cuff
US20020006961A1 (en) * 1999-05-14 2002-01-17 Katz Stanley E. Method and composition for treating mammalian nasal and sinus diseases caused by inflammatory response
DE19924440A1 (en) 1999-05-28 2000-12-07 Storz Karl Gmbh & Co Kg Shaft for a flexible endoscope
US6079755A (en) 1999-06-07 2000-06-27 Chang; Chih Chung Electromagnetic lock device
US6890329B2 (en) 1999-06-15 2005-05-10 Cryocath Technologies Inc. Defined deflection structure
CA2377430A1 (en) 1999-06-15 2000-12-21 Cryocath Technologies Inc. Deflection structure
DE29923582U1 (en) 1999-07-08 2000-12-14 Hintersdorf Steffen Device for use within the area of the nose, in particular for insertion into the nasal cavities
JP3447984B2 (en) 1999-07-21 2003-09-16 朝日インテック株式会社 Medical guidewire
US6596009B1 (en) 1999-07-28 2003-07-22 Jeffrey Jelic Retrievable endoscopic orbital floor splint
US6445939B1 (en) 1999-08-09 2002-09-03 Lightlab Imaging, Llc Ultra-small optical probes, imaging optics, and methods for using same
US6638233B2 (en) 1999-08-19 2003-10-28 Fox Hollow Technologies, Inc. Apparatus and methods for material capture and removal
US6249180B1 (en) 1999-09-08 2001-06-19 Atmel Corporation Phase noise and additive noise estimation in a QAM demodulator
US6221042B1 (en) 1999-09-17 2001-04-24 Scimed Life Systems, Inc. Balloon with reversed cones
US6939361B1 (en) 1999-09-22 2005-09-06 Nmt Medical, Inc. Guidewire for a free standing intervascular device having an integral stop mechanism
AU7735200A (en) 1999-09-28 2001-04-30 Novasys Medical, Inc. Treatment of tissue by application of energy and drugs
US7366562B2 (en) 2003-10-17 2008-04-29 Medtronic Navigation, Inc. Method and apparatus for surgical navigation
US6536437B1 (en) 1999-10-29 2003-03-25 Branislav M. Dragisic Cuffed nasal airway and anesthetic wand system
US6529756B1 (en) 1999-11-22 2003-03-04 Scimed Life Systems, Inc. Apparatus for mapping and coagulating soft tissue in or around body orifices
US6533754B1 (en) 1999-11-26 2003-03-18 Terumo Kabushiki Kaisha Catheter
US6156294A (en) 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US6450975B1 (en) 1999-12-30 2002-09-17 Advanced Cardiovascular Systems, Inc. Ultrasonic transmission guide wire
DE10102433B4 (en) 2000-01-21 2008-07-10 Pentax Corp. Flexible tube for an endoscope
US7184827B1 (en) 2000-01-24 2007-02-27 Stuart D. Edwards Shrinkage of dilatations in the body
US20010034530A1 (en) 2000-01-27 2001-10-25 Malackowski Donald W. Surgery system
US6386197B1 (en) 2000-01-27 2002-05-14 Brook D. Miller Nasal air passageway opening device
WO2001056641A1 (en) 2000-02-04 2001-08-09 C. R. Bard, Inc. Triple lumen stone balloon catheter and method
US6527753B2 (en) 2000-02-29 2003-03-04 Olympus Optical Co., Ltd. Endoscopic treatment system
US6443947B1 (en) 2000-03-01 2002-09-03 Alexei Marko Device for thermal ablation of a cavity
US6485475B1 (en) 2000-03-01 2002-11-26 The Board Of Regents Of The University Texas System Introducer needle for continuous perineural catheter placement
US6494894B2 (en) 2000-03-16 2002-12-17 Scimed Life Systems, Inc. Coated wire
AU143359S (en) 2000-03-17 2001-03-28 Astrazeneca Ab Connector for a catheter
US6440061B1 (en) 2000-03-24 2002-08-27 Donald E. Wenner Laparoscopic instrument system for real-time biliary exploration and stone removal
JP2003528688A (en) 2000-03-30 2003-09-30 シビヨン, インコーポレイテッド Apparatus and method for calibrating an endoscope
US6517478B2 (en) 2000-03-30 2003-02-11 Cbyon, Inc. Apparatus and method for calibrating an endoscope
US6984203B2 (en) 2000-04-03 2006-01-10 Neoguide Systems, Inc. Endoscope with adjacently positioned guiding apparatus
US6478776B1 (en) 2000-04-05 2002-11-12 Biocardia, Inc. Implant delivery catheter system and methods for its use
US6638268B2 (en) 2000-04-07 2003-10-28 Imran K. Niazi Catheter to cannulate the coronary sinus
US6860849B2 (en) 2000-05-08 2005-03-01 Pentax Corporation Flexible tube for an endoscope
GB0011053D0 (en) 2000-05-09 2000-06-28 Hudson John O Medical device and use thereof
WO2001089598A2 (en) 2000-05-19 2001-11-29 C.R. Bard, Inc. Guidewire with viewing capability
EP1289596B1 (en) 2000-05-31 2008-01-16 Fox Hollow Technologies, Inc. Embolization protection system for vascular procedures
US6719749B1 (en) 2000-06-01 2004-04-13 Medical Components, Inc. Multilumen catheter assembly and methods for making and inserting the same
US6409863B1 (en) 2000-06-12 2002-06-25 Scimed Life Systems, Inc. Methods of fabricating a catheter shaft having one or more guidewire ports
FR2810458B1 (en) 2000-06-16 2004-04-09 Entrelec Sa ELECTRIC INTERCONNECTION COMB
US6860688B2 (en) * 2001-06-15 2005-03-01 Danley Construction Products Pty Ltd Lockable nut system
JP3345645B2 (en) 2000-06-20 2002-11-18 東京大学長 Body cavity observation device
US6663589B1 (en) 2000-06-20 2003-12-16 Haim Halevy Catheter system
US6572590B1 (en) 2000-07-13 2003-06-03 Merit Medical Systems, Inc. Adjustable quick-release valve with toggle capability
US6440389B1 (en) 2000-07-19 2002-08-27 The General Hospital Corporation Fluorescent agents for real-time measurement of organ function
US20050107738A1 (en) 2000-07-21 2005-05-19 Slater Charles R. Occludable intravascular catheter for drug delivery and method of using the same
AU2001296217A1 (en) 2000-07-24 2002-02-05 Stereotaxis, Inc. Magnetically navigated pacing leads, and methods for delivering medical devices
RU2213530C2 (en) 2000-07-26 2003-10-10 Сунцов Виктор Владимирович Method and device for treating the cases of paranasal sinusitis
JP4429495B2 (en) 2000-07-28 2010-03-10 オリンパス株式会社 Endoscope
DE10038376C2 (en) 2000-08-07 2003-04-30 Zangenstein Elektro Door lock for the door of an electrical household appliance
US6569146B1 (en) 2000-08-18 2003-05-27 Scimed Life Systems, Inc. Method and apparatus for treating saphenous vein graft lesions
US7625335B2 (en) 2000-08-25 2009-12-01 3Shape Aps Method and apparatus for three-dimensional optical scanning of interior surfaces
US6607546B1 (en) 2000-09-01 2003-08-19 Roger E. Murken Nasal catheter
US6503263B2 (en) 2000-09-24 2003-01-07 Medtronic, Inc. Surgical micro-shaving instrument with elevator tip
US6719763B2 (en) 2000-09-29 2004-04-13 Olympus Optical Co., Ltd. Endoscopic suturing device
US7052474B2 (en) 2000-10-02 2006-05-30 Sandhill Scientific, Inc. Pharyngoesophageal monitoring systems
US6537294B1 (en) 2000-10-17 2003-03-25 Advanced Cardiovascular Systems, Inc. Delivery systems for embolic filter devices
US6702735B2 (en) 2000-10-17 2004-03-09 Charlotte Margaret Kelly Device for movement along a passage
US6585639B1 (en) 2000-10-27 2003-07-01 Pulmonx Sheath and method for reconfiguring lung viewing scope
US20020055746A1 (en) 2000-11-03 2002-05-09 Alan Burke Method and apparatus for extracting foreign bodies from nasal passages and the like
JP2002146659A (en) 2000-11-07 2002-05-22 Sumitomo Electric Ind Ltd Metallic nonwoven fabric and method for producing the same
US6571131B1 (en) 2000-11-10 2003-05-27 Biosense Webster, Inc. Deflectable catheter with modifiable handle
US6543452B1 (en) 2000-11-16 2003-04-08 Medilyfe, Inc. Nasal intubation device and system for intubation
CA2468252A1 (en) 2000-11-20 2002-05-23 Surgi-Vision, Inc. Connector and guidewire connectable thereto
US6716813B2 (en) 2000-11-28 2004-04-06 House Ear Institute Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
EP1341476A2 (en) 2000-12-01 2003-09-10 Nephros Therapeutics, Inc. Intrasvascular drug delivery device and use therefor
WO2002045598A2 (en) 2000-12-05 2002-06-13 Lumend, Inc. Catheter system for vascular re-entry from a sub-intimal space
US6500130B2 (en) 2000-12-21 2002-12-31 Scimed Life Systems, Inc. Steerable guidewire
US6672773B1 (en) 2000-12-29 2004-01-06 Amkor Technology, Inc. Optical fiber having tapered end and optical connector with reciprocal opening
KR100731007B1 (en) 2001-01-15 2007-06-22 앰코 테크놀로지 코리아 주식회사 stack-type semiconductor package
CN100491914C (en) 2001-01-30 2009-05-27 Z-凯特公司 Tool calibrator and tracker system
DE10104663A1 (en) 2001-02-02 2002-08-08 Solvay Fluor & Derivate Production of fluorine compounds
US6997931B2 (en) 2001-02-02 2006-02-14 Lsi Solutions, Inc. System for endoscopic suturing
JP3939158B2 (en) 2001-02-06 2007-07-04 オリンパス株式会社 Endoscope device
DE10105592A1 (en) 2001-02-06 2002-08-08 Achim Goepferich Placeholder for drug release in the frontal sinus
EP1913896B1 (en) * 2001-03-09 2012-12-26 Boston Scientific Limited Method for making a medical sling
US6796960B2 (en) 2001-05-04 2004-09-28 Wit Ip Corporation Low thermal resistance elastic sleeves for medical device balloons
US6712757B2 (en) 2001-05-16 2004-03-30 Stephen Becker Endoscope sleeve and irrigation device
US8403954B2 (en) 2001-05-22 2013-03-26 Sanostec Corp. Nasal congestion, obstruction relief, and drug delivery
US7532920B1 (en) 2001-05-31 2009-05-12 Advanced Cardiovascular Systems, Inc. Guidewire with optical fiber
US7140480B2 (en) 2001-06-07 2006-11-28 Drussel Wilfley Design, Llc Centrifugal clutch and cover mount assembly therefor
US6966906B2 (en) 2001-06-08 2005-11-22 Joe Denton Brown Deflection mechanism for a surgical instrument, such as a laser delivery device and/or endoscope, and method of use
EP2316394B1 (en) 2001-06-12 2016-11-23 The Johns Hopkins University Reservoir device for intraocular drug delivery
US20030013985A1 (en) 2001-07-12 2003-01-16 Vahid Saadat Method for sensing temperature profile of a hollow body organ
US7160255B2 (en) 2001-07-12 2007-01-09 Vahid Saadat Method and device for sensing and mapping temperature profile of a hollow body organ
WO2003007797A2 (en) 2001-07-17 2003-01-30 Kerberos Proximal Solutions Fluid exchange system for controlled and localized irrigation and aspiration
AUPR649601A0 (en) 2001-07-20 2001-08-09 Redfern Polymer Optics Pty Ltd Casting preforms for optical fibres
US7438701B2 (en) 2001-07-26 2008-10-21 Durect Corporation Local concentration management system
US6616659B1 (en) 2001-07-27 2003-09-09 Starion Instruments Corporation Polypectomy device and method
KR20040030963A (en) 2001-08-17 2004-04-09 앤태어스 파머, 인코퍼레이티드 Administration of insulin by jet injection
US20040127820A1 (en) 2001-09-05 2004-07-01 Clayman Ralph V. Guidewire
US20070112358A1 (en) 2001-09-06 2007-05-17 Ryan Abbott Systems and Methods for Treating Septal Defects
AUPR785001A0 (en) 2001-09-21 2001-10-18 Kleiner, Daniel E. Tamponade apparatus and method of using same
US6918882B2 (en) 2001-10-05 2005-07-19 Scimed Life Systems, Inc. Guidewire with stiffness blending connection
JP3772107B2 (en) 2001-10-12 2006-05-10 オリンパス株式会社 Endoscope system
FR2832516B1 (en) 2001-11-19 2004-01-23 Tokendo Sarl ROTARY ENDOSCOPES WITH A DEVIED DISTAL VIEW
US7488313B2 (en) 2001-11-29 2009-02-10 Boston Scientific Scimed, Inc. Mechanical apparatus and method for dilating and delivering a therapeutic agent to a site of treatment
US6832715B2 (en) 2001-12-03 2004-12-21 Scimed Life Systems, Inc. Guidewire distal tip soldering method
US6612999B2 (en) 2001-12-06 2003-09-02 Cardiac Pacemakers, Inc. Balloon actuated guide catheter
US6755812B2 (en) 2001-12-11 2004-06-29 Cardiac Pacemakers, Inc. Deflectable telescoping guide catheter
EP1319366A1 (en) 2001-12-14 2003-06-18 BrainLAB AG Magnetic navigation for a catheter
US20030114732A1 (en) 2001-12-18 2003-06-19 Advanced Cardiovascular Systems, Inc. Sheath for guiding imaging instruments
US7736301B1 (en) 2001-12-18 2010-06-15 Advanced Cardiovascular Systems, Inc. Rotatable ferrules and interfaces for use with an optical guidewire
US6939374B2 (en) 2001-12-21 2005-09-06 Scimed Life Systems, Inc. Stents, stenting systems, and related methods for agent delivery
US6955657B1 (en) 2001-12-31 2005-10-18 Advanced Cardiovascular Systems, Inc. Intra-ventricular substance delivery catheter system
US6740030B2 (en) 2002-01-04 2004-05-25 Vision Sciences, Inc. Endoscope assemblies having working channels with reduced bending and stretching resistance
US7493156B2 (en) 2002-01-07 2009-02-17 Cardiac Pacemakers, Inc. Steerable guide catheter with pre-shaped rotatable shaft
US20040158229A1 (en) 2002-01-24 2004-08-12 Quinn David G. Catheter assembly and method of catheter insertion
AU2002226252A1 (en) 2002-02-07 2003-09-02 Carag Ag Displacement device for a catheter
JP2003320031A (en) 2002-02-26 2003-11-11 Buaayu:Kk Balloon catheter
US7128718B2 (en) 2002-03-22 2006-10-31 Cordis Corporation Guidewire with deflectable tip
US7074426B2 (en) 2002-03-27 2006-07-11 Frank Kochinke Methods and drug delivery systems for the treatment of orofacial diseases
US6942635B2 (en) 2002-04-04 2005-09-13 Angiodynamics, Inc. Blood treatment catheter and method
CN1658789A (en) 2002-04-17 2005-08-24 超级测量有限公司 Endoscope structures and techniques for navigating to a target in branched structure
DE10217559B4 (en) 2002-04-19 2004-02-19 Universitätsklinikum Freiburg Device for minimally invasive, intravascular aortic valve extraction
US7610104B2 (en) 2002-05-10 2009-10-27 Cerebral Vascular Applications, Inc. Methods and apparatus for lead placement on a surface of the heart
CN100341589C (en) 2002-05-24 2007-10-10 血管技术国际股份公司 Compositions and methods for coating medical implants
EP1513440A2 (en) 2002-05-30 2005-03-16 The Board of Trustees of The Leland Stanford Junior University Apparatus and method for coronary sinus access
US7993353B2 (en) 2002-06-04 2011-08-09 Brainlab Ag Medical tracking system with universal interface
US20030229332A1 (en) 2002-06-11 2003-12-11 Scimed Life Systems, Inc. Adjustable double balloon catheter with a through lumen for stone management
GB0215270D0 (en) 2002-07-02 2002-08-14 Optinose As Nasal devices
CA2493356A1 (en) 2002-07-13 2004-01-22 Stryker Corporation System and method for performing irrigated nose and throat surgery
US7174774B2 (en) 2002-08-30 2007-02-13 Kimberly-Clark Worldwide, Inc. Method and apparatus of detecting pooling of fluid in disposable or non-disposable absorbent articles
US6783522B2 (en) 2002-09-09 2004-08-31 Angel Medical Systems, Inc. Implantable catheter having an improved check valve
US6619085B1 (en) 2002-09-12 2003-09-16 Hui-Hua Hsieh Remote-controlled lock
ITVR20020094A1 (en) 2002-09-25 2002-12-24 Vittorio Marinello APPARATUS FOR THE PROCESSING OF THE NEW SYSTEM OF TREATMENT OF THE MAXILLARY SINUSITIES, OF THE FRONTAL AND OF THE TRIGE NEVRITES AND NEVRALGIES
US7488337B2 (en) 2002-09-30 2009-02-10 Saab Mark A Apparatus and methods for bone, tissue and duct dilatation
US7169163B2 (en) 2002-09-30 2007-01-30 Bruce Becker Transnasal method and catheter for lacrimal system
US8317816B2 (en) 2002-09-30 2012-11-27 Acclarent, Inc. Balloon catheters and methods for treating paranasal sinuses
DE50202566D1 (en) 2002-10-25 2005-04-28 Brainlab Ag Apparatus and method for calibrating an element
US6899672B2 (en) 2002-11-08 2005-05-31 Scimed Life Systems, Inc. Endoscopic imaging system including removable deflection device
US7172562B2 (en) 2002-11-22 2007-02-06 Mckinley Laurence M System, method and apparatus for locating, measuring and evaluating the enlargement of a foramen
DE10254814A1 (en) 2002-11-23 2004-06-03 Fag Kugelfischer Ag Load bearing
US7343920B2 (en) 2002-12-20 2008-03-18 Toby E Bruce Connective tissue repair system
EP1435757A1 (en) 2002-12-30 2004-07-07 Andrzej Zarowski Device implantable in a bony wall of the inner ear
US8016752B2 (en) 2003-01-17 2011-09-13 Gore Enterprise Holdings, Inc. Puncturable catheter
EP1438942A1 (en) 2003-01-17 2004-07-21 Schering Oy An otorhinological drug delivery device
US20040230156A1 (en) 2003-02-13 2004-11-18 Schreck Stefan Georg Methods and devices for in-situ crosslinking of vascular tissue
CA2516559C (en) 2003-02-21 2016-09-27 Electro-Cat, Llc System and method for measuring cross-sectional areas and pressure gradients in luminal organs
US7182735B2 (en) 2003-02-26 2007-02-27 Scimed Life Systems, Inc. Elongated intracorporal medical device
US8167821B2 (en) 2003-02-26 2012-05-01 Boston Scientific Scimed, Inc. Multiple diameter guidewire
US10376711B2 (en) 2003-03-14 2019-08-13 Light Sciences Oncology Inc. Light generating guide wire for intravascular use
EP1605863B1 (en) 2003-03-14 2016-09-07 Intersect ENT, Inc. Sinus delivery of sustained release therapeutics
WO2004082736A2 (en) 2003-03-14 2004-09-30 Light Sciences Corporation Light generating device to intravascular use
US20040193073A1 (en) 2003-03-31 2004-09-30 Demello Richard M. Composite guidewire with a linear elastic distal portion
US20040267347A1 (en) 2003-05-01 2004-12-30 Cervantes Marvin John Protective elongated sleeve for stent systems
US7615005B2 (en) 2003-05-16 2009-11-10 Ethicon Endo-Surgery, Inc. Medical apparatus for use with an endoscope
US7641668B2 (en) 2003-05-16 2010-01-05 Scimed Life Systems, Inc. Fluid delivery system and related methods of use
US20040236231A1 (en) 2003-05-23 2004-11-25 Embro Corporation Light catheter for illuminating tissue structures
US7108706B2 (en) 2003-05-28 2006-09-19 Rose Biomedical Development Corporation Inflatable nasal packing device with two non-elastic, flexible bags oversized relative to nasal cavities
US7632291B2 (en) 2003-06-13 2009-12-15 Trivascular2, Inc. Inflatable implant
JP4398184B2 (en) 2003-06-24 2010-01-13 オリンパス株式会社 Endoscope
US8002740B2 (en) 2003-07-18 2011-08-23 Broncus Technologies, Inc. Devices for maintaining patency of surgically created channels in tissue
US7097612B2 (en) 2003-07-29 2006-08-29 Endoscopic Technologies, Inc. Tissue positioner
US7359755B2 (en) 2003-08-08 2008-04-15 Advanced Neuromodulation Systems, Inc. Method and apparatus for implanting an electrical stimulation lead using a flexible introducer
US6851290B1 (en) 2003-08-11 2005-02-08 Absolute Access & Security Products, Inc. Door lock assembly and locking system for hinged double-acting impact-traffic doors
EP1667584B1 (en) 2003-08-26 2008-12-10 Zimmer Spine, Inc. Access systems for minimally invasive surgery
US7313430B2 (en) 2003-08-28 2007-12-25 Medtronic Navigation, Inc. Method and apparatus for performing stereotactic surgery
US20050055077A1 (en) 2003-09-05 2005-03-10 Doron Marco Very low profile medical device system having an adjustable balloon
US20050113687A1 (en) 2003-09-15 2005-05-26 Atrium Medical Corporation Application of a therapeutic substance to a tissue location using a porous medical device
US20050059931A1 (en) 2003-09-16 2005-03-17 Venomatrix Methods and apparatus for localized and semi-localized drug delivery
US20050113850A1 (en) 2003-10-08 2005-05-26 Tagge Bryan C. Apparatus, system, and method for middle turbinate medializer
US8014849B2 (en) 2003-11-21 2011-09-06 Stryker Corporation Rotational markers
JP3864344B2 (en) 2003-12-05 2006-12-27 フジノン株式会社 Endoscope insertion aid
US7237313B2 (en) 2003-12-05 2007-07-03 Boston Scientific Scimed, Inc. Elongated medical device for intracorporal use
USD501677S1 (en) 2003-12-11 2005-02-08 Bruce B. Becker Dilatation balloon catheter
US20050131316A1 (en) 2003-12-15 2005-06-16 Cook Incorporated Guidewire with flexible tip
US20070020196A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension
CA2555473A1 (en) 2004-02-17 2005-09-01 Traxtal Technologies Inc. Method and apparatus for registration, verification, and referencing of internal organs
US7988705B2 (en) 2004-03-06 2011-08-02 Lumen Biomedical, Inc. Steerable device having a corewire within a tube and combination with a functional medical component
US20060211752A1 (en) 2004-03-16 2006-09-21 Kohn Leonard D Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression
US7282057B2 (en) 2004-03-30 2007-10-16 Wilson-Cook Medical, Inc. Pediatric atresia magnets
US7452351B2 (en) 2004-04-16 2008-11-18 Kyphon Sarl Spinal diagnostic methods and apparatus
US20050234507A1 (en) 2004-04-16 2005-10-20 Jeff Geske Medical tool for access to internal tissue
US7559925B2 (en) 2006-09-15 2009-07-14 Acclarent Inc. Methods and devices for facilitating visualization in a surgical environment
US7419497B2 (en) 2004-04-21 2008-09-02 Acclarent, Inc. Methods for treating ethmoid disease
US20060004323A1 (en) 2004-04-21 2006-01-05 Exploramed Nc1, Inc. Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures
US9089258B2 (en) 2004-04-21 2015-07-28 Acclarent, Inc. Endoscopic methods and devices for transnasal procedures
US8894614B2 (en) 2004-04-21 2014-11-25 Acclarent, Inc. Devices, systems and methods useable for treating frontal sinusitis
US8747389B2 (en) 2004-04-21 2014-06-10 Acclarent, Inc. Systems for treating disorders of the ear, nose and throat
US8764729B2 (en) 2004-04-21 2014-07-01 Acclarent, Inc. Frontal sinus spacer
US9399121B2 (en) 2004-04-21 2016-07-26 Acclarent, Inc. Systems and methods for transnasal dilation of passageways in the ear, nose or throat
US8864787B2 (en) 2004-04-21 2014-10-21 Acclarent, Inc. Ethmoidotomy system and implantable spacer devices having therapeutic substance delivery capability for treatment of paranasal sinusitis
US7803150B2 (en) 2004-04-21 2010-09-28 Acclarent, Inc. Devices, systems and methods useable for treating sinusitis
US7720521B2 (en) 2004-04-21 2010-05-18 Acclarent, Inc. Methods and devices for performing procedures within the ear, nose, throat and paranasal sinuses
US7361168B2 (en) 2004-04-21 2008-04-22 Acclarent, Inc. Implantable device and methods for delivering drugs and other substances to treat sinusitis and other disorders
US7654997B2 (en) 2004-04-21 2010-02-02 Acclarent, Inc. Devices, systems and methods for diagnosing and treating sinusitus and other disorders of the ears, nose and/or throat
US7410480B2 (en) 2004-04-21 2008-08-12 Acclarent, Inc. Devices and methods for delivering therapeutic substances for the treatment of sinusitis and other disorders
US7462175B2 (en) 2004-04-21 2008-12-09 Acclarent, Inc. Devices, systems and methods for treating disorders of the ear, nose and throat
US20060063973A1 (en) 2004-04-21 2006-03-23 Acclarent, Inc. Methods and apparatus for treating disorders of the ear, nose and throat
US20070167682A1 (en) 2004-04-21 2007-07-19 Acclarent, Inc. Endoscopic methods and devices for transnasal procedures
US9101384B2 (en) 2004-04-21 2015-08-11 Acclarent, Inc. Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, Nose and/or throat
US20070208252A1 (en) 2004-04-21 2007-09-06 Acclarent, Inc. Systems and methods for performing image guided procedures within the ear, nose, throat and paranasal sinuses
US20050244472A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Intraocular drug delivery systems containing excipients with reduced toxicity and related methods
JP4767252B2 (en) 2004-06-14 2011-09-07 ヌームアールエックス・インコーポレーテッド Lung access device
US9289576B2 (en) 2004-06-17 2016-03-22 W. L. Gore & Associates, Inc. Catheter assembly
CA2574013A1 (en) 2004-07-14 2006-01-19 By-Pass, Inc. Material delivery system
US8277386B2 (en) 2004-09-27 2012-10-02 Volcano Corporation Combination sensor guidewire and methods of use
FR2859377B1 (en) 2004-10-22 2006-05-12 Bertrand Lombard THREE DIMENSIONAL LOCATION DEVICE
US7235099B1 (en) 2004-12-14 2007-06-26 Micromedics, Inc. Sphenoid sinus stent
EP1838215B1 (en) 2005-01-18 2012-08-01 Philips Electronics LTD Electromagnetically tracked k-wire device
US8109981B2 (en) 2005-01-25 2012-02-07 Valam Corporation Optical therapies and devices
US20060173382A1 (en) 2005-01-31 2006-08-03 John Schreiner Guidewire with superelastic core
EP2298318A1 (en) 2005-04-04 2011-03-23 Sinexus, Inc. Device and methods for treating paranasal sinus conditions
US20080051804A1 (en) 2005-05-05 2008-02-28 Cottler Shayn P Tube, stent and collar insertion device
US7896891B2 (en) 2005-05-20 2011-03-01 Neotract, Inc. Apparatus and method for manipulating or retracting tissue and anatomical structure
US8951225B2 (en) 2005-06-10 2015-02-10 Acclarent, Inc. Catheters with non-removable guide members useable for treatment of sinusitis
US8197433B2 (en) 2005-06-20 2012-06-12 Otomedics Advanced Technologies, Ltd. Ear tubes
DE602006017093D1 (en) 2005-09-20 2010-11-04 Medsys S A DEVICE AND METHOD FOR CHECKING A REMOTE DEVICE
USD534216S1 (en) 2005-09-23 2006-12-26 Acclarent, Inc. Anatomical model and demonstration/training device
US7648367B1 (en) 2005-09-23 2010-01-19 Acclarent, Inc. Anatomical models and methods for training and demonstration of medical procedures
US8114113B2 (en) 2005-09-23 2012-02-14 Acclarent, Inc. Multi-conduit balloon catheter
AU2007221150B2 (en) 2006-02-27 2012-09-20 Ahm Technologies, Inc. Eustachian tube device and method
US8585753B2 (en) 2006-03-04 2013-11-19 John James Scanlon Fibrillated biodegradable prosthesis
US7520876B2 (en) 2006-04-21 2009-04-21 Entellus Medical, Inc. Device and method for treatment of sinusitis
EP2023826B1 (en) 2006-05-12 2017-06-21 ArthroCare Corporation Middle turbinate medializer
US20070269385A1 (en) 2006-05-18 2007-11-22 Mercator Medsystems, Inc Devices, methods, and systems for delivering therapeutic agents for the treatment of sinusitis, rhinitis, and other disorders
US8535707B2 (en) 2006-07-10 2013-09-17 Intersect Ent, Inc. Devices and methods for delivering active agents to the osteomeatal complex
US9820688B2 (en) 2006-09-15 2017-11-21 Acclarent, Inc. Sinus illumination lightwire device
US7535991B2 (en) 2006-10-16 2009-05-19 Oraya Therapeutics, Inc. Portable orthovoltage radiotherapy
US7634233B2 (en) 2006-11-27 2009-12-15 Chung Shan Institute Of Science And Technology Transmission system with interference avoidance capability and method thereof
US8104483B2 (en) 2006-12-26 2012-01-31 The Spectranetics Corporation Multi-port light delivery catheter and methods for the use thereof
JP2008161491A (en) 2006-12-28 2008-07-17 Asahi Intecc Co Ltd Medical guide wire
US9216112B2 (en) 2007-04-19 2015-12-22 Acclarent, Inc. System and method for the simultaneous bilateral placement of pressure equalization tubes
FR2916144A1 (en) 2007-05-14 2008-11-21 Olivier Pascal Bruno Rollet Endotracheal catheter for use during surgery, has tube including distal end connected to collar and another end connected to circular pusher, where pusher is actuated outside buccal cavity by user after endotracheal intubation
EP2160140B1 (en) 2007-06-26 2014-11-05 Galit Avior Eustachian tube device
WO2009037689A2 (en) 2007-09-20 2009-03-26 Estimme Ltd Electrical stimulation in the middle ear for treatment of hearing related disorders
US20090088728A1 (en) 2007-09-28 2009-04-02 Dollar Michael L Malleable sleeve for balloon catheter and endoscopic surgical method
USD590502S1 (en) 2007-11-13 2009-04-14 Karl Storz Gmbh & Co. Kg Grip for laparoscope
US20100198191A1 (en) 2007-12-20 2010-08-05 Acclarent, Inc. Method and system for treating target tissue within the eustachian tube
US20100274188A1 (en) 2007-12-20 2010-10-28 Acclarent, Inc. Method and System for Treating Target Tissue Within the Eustachian Tube
US20090163890A1 (en) 2007-12-20 2009-06-25 Acclarent, Inc. Method and System for Accessing, Diagnosing and Treating Target Tissue Regions Within the Middle Ear and the Eustachian Tube
USD586465S1 (en) 2008-05-09 2009-02-10 Lifescan Scotland Limited Handheld lancing device
USD586916S1 (en) 2008-05-09 2009-02-17 Lifescan Scotland, Ltd. Handheld lancing device
CA2765190C (en) 2008-05-27 2016-07-19 The University Of Melbourne Methods of treating mammals with eustachian tube dysfunctions
US20100087811A1 (en) 2008-10-06 2010-04-08 Coaptus Medical Corporation Systems and Methods for Controlling Patient Catheters
USD630321S1 (en) 2009-05-08 2011-01-04 Angio Dynamics, Inc. Probe handle
US8608360B2 (en) 2009-05-18 2013-12-17 Günther Nath Liquid light guide having position retaining function
USD633206S1 (en) 2009-09-11 2011-02-22 Stryker Trauma Ag Connector

Patent Citations (108)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2899227A (en) * 1959-08-11 Charles-louis gschwend
US504424A (en) * 1893-09-05 Oscar de pezzer
US513667A (en) * 1894-01-30 Sliding staple for hasps
US446173A (en) * 1891-02-10 Hasp and staple
US705346A (en) * 1901-11-02 1902-07-22 Jonathan R Hamilton Dilator.
US816792A (en) * 1904-09-06 1906-04-03 Oliver H P Green Lock.
US798775A (en) * 1905-04-13 1905-09-05 Valorus A Bradbury Dispensing-bottle.
US2201749A (en) * 1939-02-15 1940-05-21 Vandegrift Middleton Expanding vein tube
US2493326A (en) * 1949-03-01 1950-01-03 John H Trinder Tampon for control of intractable nasal hemorrhages
US2847997A (en) * 1956-01-13 1958-08-19 James J Tibone Catheter
US2906179A (en) * 1957-01-28 1959-09-29 North American Aviation Inc Vector gage
US3037286A (en) * 1957-01-28 1962-06-05 North American Aviation Inc Vector gage
US2995832A (en) * 1960-08-01 1961-08-15 Alderson Res Lab Inc Training aid for intravenous therapy
US3173418A (en) * 1961-01-10 1965-03-16 Ostap E Baran Double-wall endotracheal cuff
US3435826A (en) * 1964-05-27 1969-04-01 Edwards Lab Inc Embolectomy catheter
US3393073A (en) * 1965-04-16 1968-07-16 Eastman Kodak Co High contrast photographic emulsions
US3376659A (en) * 1965-06-09 1968-04-09 Bard Inc C R Demonstration device
US3384970A (en) * 1965-09-22 1968-05-28 Boice Gages Inc Precision coordinates measurement apparatus for gaging and layout operations
US3509638A (en) * 1966-08-04 1970-05-05 Midland Ross Corp Treating apparatus
US3506005A (en) * 1967-02-23 1970-04-14 Arthur S Gilio Pressure infusion device for medical use
US3552384A (en) * 1967-07-03 1971-01-05 American Hospital Supply Corp Controllable tip guide body and catheter
US3515888A (en) * 1967-10-27 1970-06-02 California Computer Products Manual optical digitizer
US3948262A (en) * 1969-04-01 1976-04-06 Alza Corporation Novel drug delivery device
US3967618A (en) * 1969-04-01 1976-07-06 Alza Corporation Drug delivery device
US4069307A (en) * 1970-10-01 1978-01-17 Alza Corporation Drug-delivery device comprising certain polymeric materials for controlled release of drug
US3731963A (en) * 1971-04-20 1973-05-08 R Pond Electrically actuated lock mechanism
US3804081A (en) * 1971-07-29 1974-04-16 Olympus Optical Co Endoscope
US3802096A (en) * 1971-08-09 1974-04-09 H Matern Composite model for medical study
US3948254A (en) * 1971-11-08 1976-04-06 Alza Corporation Novel drug delivery device
US3871365A (en) * 1972-06-19 1975-03-18 Machida Endoscope Co Ltd Endoscope
US3800788A (en) * 1972-07-12 1974-04-02 N White Antral catheter for reduction of fractures
US3894538A (en) * 1972-08-10 1975-07-15 Siemens Ag Device for supplying medicines
US4016251A (en) * 1972-08-17 1977-04-05 Alza Corporation Vaginal drug dispensing device
US3792391A (en) * 1972-12-18 1974-02-12 L Ewing Electrically operated two position electromechanical mechanism
US4450150A (en) * 1973-05-17 1984-05-22 Arthur D. Little, Inc. Biodegradable, implantable drug delivery depots, and method for preparing and using the same
US3859993A (en) * 1973-08-27 1975-01-14 Daniel G Bitner Operating table accessory
US4102342A (en) * 1975-12-29 1978-07-25 Taichiro Akiyama Valved device
US4138151A (en) * 1976-07-30 1979-02-06 Olympus Optical Company Limited Detent device for locking the lid of a cassette receiving compartment of a tape recorder
US4207890A (en) * 1977-01-04 1980-06-17 Mcneilab, Inc. Drug-dispensing device and method
US4209919A (en) * 1977-07-23 1980-07-01 Taichiro Akiyama Model of living body
US4184497A (en) * 1977-08-26 1980-01-22 University Of Utah Peritoneal dialysis catheter
US4198766A (en) * 1978-06-21 1980-04-22 Baxter Travenol Laboratories, Inc. Intravenous training/demonstration aid
US4213095A (en) * 1978-08-04 1980-07-15 Bell Telephone Laboratories, Incorporated Feedforward nonlinear equalization of modulated data signals
US4217898A (en) * 1978-10-23 1980-08-19 Alza Corporation System with microporous reservoir having surface for diffusional delivery of agent
US4268115A (en) * 1979-06-01 1981-05-19 Tetra-Tech, Inc. Quick-release fiber-optic connector
US4249531A (en) * 1979-07-05 1981-02-10 Alza Corporation Bioerodible system for delivering drug manufactured from poly(carboxylic acid)
US4748869A (en) * 1979-08-14 1988-06-07 Nissan Motor Company, Limited Automatic transmission for an automotive vehicle
US4338941A (en) * 1980-09-10 1982-07-13 Payton Hugh W Apparatus for arresting posterior nosebleeds
US4388941A (en) * 1980-11-06 1983-06-21 Danfoss A/S Apparatus for producing a rotary speed-dependent control pressure
US4437856A (en) * 1981-02-09 1984-03-20 Alberto Valli Peritoneal catheter device for dialysis
US4459977A (en) * 1981-03-27 1984-07-17 Veronique Pizon Coronary sinus retroperfusion apparatus for the treatment of myocardial ischemia
US4603564A (en) * 1981-06-17 1986-08-05 Bauer Kaba Ag Lock cylinder with integrated electromagnetic locking system
US4435716A (en) * 1981-09-14 1984-03-06 Adrian Zandbergen Method of making a conical spiral antenna
US4571239A (en) * 1982-03-01 1986-02-18 Heyman Arnold M Catheter-stylet assembly for slipover urethral instruments
US4464175A (en) * 1982-08-25 1984-08-07 Altman Alan R Multipurpose tamponade and thrombosclerotherapy tube
US4499899A (en) * 1983-01-21 1985-02-19 Brimfield Precision, Inc. Fiber-optic illuminated microsurgical scissors
US4581017B1 (en) * 1983-03-07 1994-05-17 Bard Inc C R Catheter systems
US4581017A (en) * 1983-03-07 1986-04-08 Harvinder Sahota Catheter systems
US4639244A (en) * 1983-05-03 1987-01-27 Nabil I. Rizk Implantable electrophoretic pump for ionic drugs and associated methods
US4564364A (en) * 1983-05-26 1986-01-14 Alza Corporation Active agent dispenser
US4737141A (en) * 1983-07-26 1988-04-12 Fundatech S.A. Method of draining the maxillary sinus for the treatment of maxillary sinusitis
US4675613A (en) * 1983-08-11 1987-06-23 Hewlett-Packard Company Noise compensated synchronous detector system
US4571240A (en) * 1983-08-12 1986-02-18 Advanced Cardiovascular Systems, Inc. Catheter having encapsulated tip marker
US4925445A (en) * 1983-09-16 1990-05-15 Fuji Terumo Co., Ltd. Guide wire for catheter
US4585000A (en) * 1983-09-28 1986-04-29 Cordis Corporation Expandable device for treating intravascular stenosis
US4606346A (en) * 1984-01-11 1986-08-19 Olle Berg Intranasal device
US4589868A (en) * 1984-03-12 1986-05-20 Dretler Stephen P Expandable dilator-catheter
US4851228A (en) * 1984-06-20 1989-07-25 Merck & Co., Inc. Multiparticulate controlled porosity osmotic
US4596528A (en) * 1984-07-02 1986-06-24 Lewis Leonard A Simulated skin and method
US4637389A (en) * 1985-04-08 1987-01-20 Heyden Eugene L Tubular device for intubation
US4607622A (en) * 1985-04-11 1986-08-26 Charles D. Fritch Fiber optic ocular endoscope
US4645495A (en) * 1985-06-26 1987-02-24 Vaillancourt Vincent L Vascular access implant needle patch
US4897651A (en) * 1985-10-15 1990-01-30 Ing. C. Olivetti & C., S.P.A. Key with selective symbol display and keyboard using such key
US4748986A (en) * 1985-11-26 1988-06-07 Advanced Cardiovascular Systems, Inc. Floppy guide wire with opaque tip
US4669469A (en) * 1986-02-28 1987-06-02 Devices For Vascular Intervention Single lumen atherectomy catheter device
US4672961A (en) * 1986-05-19 1987-06-16 Davies David H Retrolasing catheter and method
US4795439A (en) * 1986-06-06 1989-01-03 Edward Weck Incorporated Spiral multi-lumen catheter
US4854330A (en) * 1986-07-10 1989-08-08 Medrad, Inc. Formed core catheter guide wire assembly
US4920967A (en) * 1986-07-18 1990-05-01 Pfizer Hospital Products Group, Inc. Doppler tip wire guide
US4847258A (en) * 1986-08-26 1989-07-11 Ciba-Geigy Corporation Substituted benzoylphenylureas compounds useful as pesticides
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
US4726772A (en) * 1986-12-01 1988-02-23 Kurt Amplatz Medical simulator
US4819619A (en) * 1987-01-16 1989-04-11 Augustine Scott D Device for inserting a nasal tube
US4815478A (en) * 1987-02-17 1989-03-28 Medtronic Versaflex, Inc. Steerable guidewire with deflectable tip
US4736970A (en) * 1987-03-09 1988-04-12 Mcgourty Thomas K Electrically controlled door lock
US4811743A (en) * 1987-04-21 1989-03-14 Cordis Corporation Catheter guidewire
US4748969A (en) * 1987-05-07 1988-06-07 Circon Corporation Multi-lumen core deflecting endoscope
US4755171A (en) * 1987-05-29 1988-07-05 Tennant Jerald L Tubular surgical device
US4796629A (en) * 1987-06-03 1989-01-10 Joseph Grayzel Stiffened dilation balloon catheter device
US4846186A (en) * 1988-01-12 1989-07-11 Cordis Corporation Flexible guidewire
US4917667A (en) * 1988-02-11 1990-04-17 Retroperfusion Systems, Inc. Retroperfusion balloon catheter and method
US4940062A (en) * 1988-05-26 1990-07-10 Advanced Cardiovascular Systems, Inc. Guiding member with deflectable tip
US4917419A (en) * 1988-08-22 1990-04-17 Mora Jr Saturnino F Electromechanical door lock system
US4898577A (en) * 1988-09-28 1990-02-06 Advanced Cardiovascular Systems, Inc. Guiding cathether with controllable distal tip
US5195984A (en) * 1988-10-04 1993-03-23 Expandable Grafts Partnership Expandable intraluminal graft
US4943275A (en) * 1988-10-14 1990-07-24 Abiomed Limited Partnership Insertable balloon with curved support
US4919112A (en) * 1989-04-07 1990-04-24 Schott Fiber Optics Low-cost semi-disposable endoscope
US4919112B1 (en) * 1989-04-07 1993-12-28 Low-cost semi-disposable endoscope
US5234456A (en) * 1990-02-08 1993-08-10 Pfizer Hospital Products Group, Inc. Hydrophilic stent
WO1992015286A1 (en) * 1991-02-27 1992-09-17 Nova Pharmaceutical Corporation Anti-infective and anti-inflammatory releasing systems for medical devices
US5211952A (en) * 1991-04-12 1993-05-18 University Of Southern California Contraceptive methods and formulations for use therein
US5246455A (en) * 1991-05-17 1993-09-21 Micromedics, Inc. Middle meatal antrostomy ventilation tube
US5376376A (en) * 1992-01-13 1994-12-27 Li; Shu-Tung Resorbable vascular wound dressings
US5443458A (en) * 1992-12-22 1995-08-22 Advanced Cardiovascular Systems, Inc. Multilayered biodegradable stent and method of manufacture
US5741333A (en) * 1995-04-12 1998-04-21 Corvita Corporation Self-expanding stent for a medical device to be introduced into a cavity of a body
US5824049A (en) * 1995-06-07 1998-10-20 Med Institute, Inc. Coated implantable medical device
US5693065A (en) * 1996-06-25 1997-12-02 Rains, Iii; B. Manrin Frontal sinus stent
US6652575B2 (en) * 1998-05-05 2003-11-25 Scimed Life Systems, Inc. Stent with smooth ends

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Shikani A. "A New Middle Meatal Antrostomy Stent for Functional Endoscopic Sinus Surgery". May 1994. Larynoscope 104: May 1994. Pages 638-641. *

Cited By (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8740929B2 (en) 2001-02-06 2014-06-03 Acclarent, Inc. Spacing device for releasing active substances in the paranasal sinus
US7951131B2 (en) 2003-03-14 2011-05-31 Intersect Ent, Inc. Sinus delivery of sustained release therapeutics
US11291812B2 (en) 2003-03-14 2022-04-05 Intersect Ent, Inc. Sinus delivery of sustained release therapeutics
US20090192489A1 (en) * 2003-03-14 2009-07-30 Eaton Donald J Sinus delivery of sustained release therapeutics
US20090192492A1 (en) * 2003-03-14 2009-07-30 Eaton Donald J Sinus delivery of sustained release therapeutics
US20090192488A1 (en) * 2003-03-14 2009-07-30 Eaton Donald J Sinus delivery of sustained release therapeutics
US20090192491A1 (en) * 2003-03-14 2009-07-30 Eaton Donald J Sinus delivery of sustained release therapeutics
US7662142B2 (en) 2003-03-14 2010-02-16 Sinexus, Inc. Sinus delivery of sustained release therapeutics
US7662141B2 (en) 2003-03-14 2010-02-16 Sinexus, Inc. Sinus delivery of sustained release therapeutics
US7686798B2 (en) 2003-03-14 2010-03-30 Sinexus, Inc. Sinus delivery of sustained release therapeutics
US7691094B2 (en) 2003-03-14 2010-04-06 Intersect Ent, Inc. Sinus delivery of sustained release therapeutics
US7951133B2 (en) 2003-03-14 2011-05-31 Intersect Ent, Inc. Sinus delivery of sustained release therapeutics
US7713255B2 (en) 2003-03-14 2010-05-11 Intersect Ent, Inc. Sinus delivery of sustained release therapeutics
US7544192B2 (en) 2003-03-14 2009-06-09 Sinexus, Inc. Sinus delivery of sustained release therapeutics
US20050043706A1 (en) * 2003-03-14 2005-02-24 Eaton Donald J. Sinus delivery of sustained release therapeutics
US8109918B2 (en) 2003-03-14 2012-02-07 Intersect Ent, Inc. Sinus delivery of sustained release therapeutics
US7951132B2 (en) 2003-03-14 2011-05-31 Intersect, ENT, Inc. Sinus delivery of sustained release therapeutics
US7951130B2 (en) 2003-03-14 2011-05-31 Intersect Ent, Inc. Sinus delivery of sustained release therapeutics
US7951134B2 (en) 2003-03-14 2011-05-31 Intersect Ent, Inc. Sinus delivery of sustained release therapeutics
US7951135B2 (en) 2003-03-14 2011-05-31 Intersect Ent, Inc. Sinus delivery of sustained release therapeutics
US20090192490A1 (en) * 2003-03-14 2009-07-30 Eaton Donald J Sinus delivery of sustained release therapeutics
US8025635B2 (en) 2005-04-04 2011-09-27 Intersect Ent, Inc. Device and methods for treating paranasal sinus conditions
US9585681B2 (en) 2005-04-04 2017-03-07 Intersect Ent, Inc. Device and methods for treating paranasal sinus conditions
US8337454B2 (en) 2005-04-04 2012-12-25 Intersect Ent, Inc. Device and methods for treating paranasal sinus conditions
US8858974B2 (en) 2005-04-04 2014-10-14 Intersect Ent, Inc. Device and methods for treating paranasal sinus conditions
US8740839B2 (en) 2005-04-04 2014-06-03 Intersect Ent, Inc. Device and methods for treating paranasal sinus conditions
US11123091B2 (en) 2005-04-04 2021-09-21 Intersect Ent, Inc. Device and methods for treating paranasal sinus conditions
US8535707B2 (en) 2006-07-10 2013-09-17 Intersect Ent, Inc. Devices and methods for delivering active agents to the osteomeatal complex
US8802131B2 (en) 2006-07-10 2014-08-12 Intersect Ent, Inc. Devices and methods for delivering active agents to the osteomeatal complex
US8585731B2 (en) 2007-12-18 2013-11-19 Intersect Ent, Inc. Self-expanding devices and methods therefor
US11110210B2 (en) 2007-12-18 2021-09-07 Intersect Ent, Inc. Self-expanding devices and methods therefor
US8585730B2 (en) 2007-12-18 2013-11-19 Intersect Ent, Inc. Self-expanding devices and methods therefor
US10010651B2 (en) 2007-12-18 2018-07-03 Intersect Ent, Inc. Self-expanding devices and methods therefor
US11497835B2 (en) 2007-12-18 2022-11-15 Intersect Ent, Inc. Self-expanding devices and methods therefor
US8986341B2 (en) 2007-12-18 2015-03-24 Intersect Ent, Inc. Self-expanding devices and methods therefor
US11654216B2 (en) 2007-12-18 2023-05-23 Intersect Ent, Inc. Self-expanding devices and methods therefor
US11826494B2 (en) 2007-12-18 2023-11-28 Intersect Ent, Inc. Self-expanding devices and methods therefor
US10471185B2 (en) 2007-12-18 2019-11-12 Intersect Ent, Inc. Self-expanding devices and methods therefor
US9782283B2 (en) 2008-08-01 2017-10-10 Intersect Ent, Inc. Methods and devices for crimping self-expanding devices
US8763222B2 (en) 2008-08-01 2014-07-01 Intersect Ent, Inc. Methods and devices for crimping self-expanding devices
US20110202037A1 (en) * 2008-08-18 2011-08-18 Bolger William E Fluid delivery catheter apparatus
US20110201996A1 (en) * 2008-08-27 2011-08-18 Melder Patrick C Nasal ventilation system and method of using same
US8945142B2 (en) 2008-08-27 2015-02-03 Cook Medical Technologies Llc Delivery system for implanting nasal ventilation tube
US20100100170A1 (en) * 2008-10-22 2010-04-22 Boston Scientific Scimed, Inc. Shape memory tubular stent with grooves
US9980806B2 (en) 2008-10-22 2018-05-29 Boston Scientific Scimed, Inc. Shape memory tubular stent with grooves
US11484693B2 (en) 2009-05-15 2022-11-01 Intersect Ent, Inc. Expandable devices and methods for treating a nasal or sinus condition
US10357640B2 (en) 2009-05-15 2019-07-23 Intersect Ent, Inc. Expandable devices and methods for treating a nasal or sinus condition
US8435261B2 (en) 2009-07-15 2013-05-07 Regents Of The University Of Minnesota Treatment and placement device for sinusitis applications
US9629644B2 (en) 2010-08-30 2017-04-25 SinuSys Corporation Devices and methods for dilating a paranasal sinus opening and for treating sinusitis
US9498239B2 (en) 2010-08-30 2016-11-22 SinuSys Corporation Devices and methods for inserting a sinus dilator
US9597179B2 (en) 2011-07-25 2017-03-21 Rainbow Medical Ltd. Sinus stent
US8998985B2 (en) 2011-07-25 2015-04-07 Rainbow Medical Ltd. Sinus stent
US9149616B2 (en) 2012-02-29 2015-10-06 SinuSys Corporation Devices and methods for dilating a paranasal sinus opening and for treating sinusitis
US9138569B2 (en) 2012-02-29 2015-09-22 SinuSys Corporation Devices and methods for dilating a paranasal sinus opening and for treating sinusitis
US9504812B2 (en) 2012-02-29 2016-11-29 SinuSys Corporation Devices and methods for dilating a paranasal sinus opening and for treating sinusitis
US9597485B2 (en) 2012-02-29 2017-03-21 SinuSys Corporation Devices and methods for dilating a paranasal sinus opening and for treating sinusitis
US10406332B2 (en) 2013-03-14 2019-09-10 Intersect Ent, Inc. Systems, devices, and method for treating a sinus condition
US11672960B2 (en) 2013-03-14 2023-06-13 Intersect Ent, Inc. Systems, devices, and method for treating a sinus condition
US10232152B2 (en) 2013-03-14 2019-03-19 Intersect Ent, Inc. Systems, devices, and method for treating a sinus condition
US9687263B2 (en) 2013-05-30 2017-06-27 SinuSys Corporation Devices and methods for inserting a sinus dilator
US10183153B2 (en) 2013-09-27 2019-01-22 Acclarent, Inc. Sinus wall implant
US9694163B2 (en) 2013-12-17 2017-07-04 Biovision Technologies, Llc Surgical device for performing a sphenopalatine ganglion block procedure
US9510743B2 (en) 2013-12-17 2016-12-06 Biovision Technologies, Llc Stabilized surgical device for performing a sphenopalatine ganglion block procedure
US10016580B2 (en) 2013-12-17 2018-07-10 Biovision Technologies, Llc Methods for treating sinus diseases
US10420459B2 (en) 2013-12-17 2019-09-24 Biovision Technologies, Llc Method of performing a sphenopalatine ganglion block procedure
US10046143B2 (en) 2013-12-17 2018-08-14 Biovision Technologies Llc Surgical device for performing a sphenopalatine ganglion block procedure
US9248266B2 (en) 2013-12-17 2016-02-02 Biovision Technologies, Llc Method of performing a sphenopalatine ganglion block procedure
US10589072B2 (en) 2013-12-17 2020-03-17 Biovision Technologies, Llc Methods for treating sinus diseases
US9839347B2 (en) 2013-12-17 2017-12-12 Biovision Technologies Llc Method of performing a sphenopalatine ganglion block procedure
US9516995B2 (en) 2013-12-17 2016-12-13 Biovision Technologies, Llc Surgical device for performing a sphenopalatine ganglion block procedure
US11058855B2 (en) 2013-12-17 2021-07-13 Biovision Technologies, Llc Surgical device for performing a sphenopalatine ganglion block procedure
US9956384B2 (en) 2014-01-24 2018-05-01 Cook Medical Technologies Llc Articulating balloon catheter and method for using the same
US10232082B2 (en) 2015-06-29 2019-03-19 480 Biomedical, Inc. Implantable scaffolds for treatment of sinusitis
US10857013B2 (en) 2015-06-29 2020-12-08 Lyra Therapeutics, Inc. Scaffold loading and delivery systems
US10159586B2 (en) 2015-06-29 2018-12-25 480 Biomedical Inc. Scaffold loading and delivery systems
US10278812B2 (en) 2015-06-29 2019-05-07 480 Biomedical, Inc. Implantable scaffolds and methods for treatment of sinusitis
US10973664B2 (en) 2015-12-30 2021-04-13 Lyra Therapeutics, Inc. Scaffold loading and delivery systems
US10201639B2 (en) 2017-05-01 2019-02-12 480 Biomedical, Inc. Drug-eluting medical implants
US10525240B1 (en) 2018-06-28 2020-01-07 Sandler Scientific LLC Sino-nasal rinse delivery device with agitation, flow-control and integrated medication management system

Also Published As

Publication number Publication date
US20040116958A1 (en) 2004-06-17
DE50213523D1 (en) 2009-06-18
WO2002062269A1 (en) 2002-08-15
EP1357861B1 (en) 2009-05-06
DE10105592A1 (en) 2002-08-08
US8740929B2 (en) 2014-06-03
ATE430534T1 (en) 2009-05-15
EP1357861A1 (en) 2003-11-05

Similar Documents

Publication Publication Date Title
US8740929B2 (en) Spacing device for releasing active substances in the paranasal sinus
US20210378698A1 (en) Device and methods for treating paranasal sinus conditions
Quarterman et al. Evolution of drug-eluting biomedical implants for sustained drug delivery
KR101538748B1 (en) Implantable drug delivery device and methods for treatment of the bladder and other body vesicles or lumens
ES2252962T3 (en) MEDICINAL PRODUCTS WITH DELAYED PHARMACOLOGICAL ACTIVITY, AND PROCEDURE FOR PREPARATION.
US6939374B2 (en) Stents, stenting systems, and related methods for agent delivery
US20070270939A1 (en) Drug Delivery Device
AU2013274170B2 (en) Biodegradable, active ingredient-eluting structural support
US20080086214A1 (en) Medical device having a sleeve valve with bioactive agent
US20080051911A1 (en) Stent with antimicrobial drainage lumen surface
AU2007272986A1 (en) Implantable sustained drug delivery device for releasing active agents to the osteomeatal complex
EP3277363B1 (en) Devices for local delivery of drug to upper urinary tract

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION